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ABSTRACT 
It has been found that low molecular mass copper(II) complexes are effective in the 
treatment of rheumat.)id arthritis (RA). Increasing the amount of copper associated 
with low molecular mass ligands in plasma helps to alleviate the symptoms of 
rheumatoid arthritis. Low molecular weight ligand, 
3,5-bis[(aminoethyl)dhanediamideJ-4-oxahexacyclododecane (PCUA) was 
investigated using glass electrode potentiometry, UV!Visible spectroscopy, nuclear 
magnetic resonance :.pectroscopy, speciation modelling as well as blood plasma 
modelling. 
Protonation and stab lity constants were determined at 25°C in 0.15 mol dm-3 cr 
(Na+) using glass electrode potentiometry and the ESTA (Equilibrium Simulation for 
Titration Analysis) library of computer speciation modelling programs. The stability 
constants were determined for complexation ofPCUA with divalent copper(Jr), 
zinc(II) and calcium( II). 
UV!Visible spectrost:opy was used to investigate the structures of the different 
copper(II) solution sDecies. It confirmed the square planar MN4 type of coordination 
for MLRl species. Unfortunately, it was difficult to obtain spectra for MLl1.2 species 
due to a lot of noise/interferences. 
Nuclcar magnetic re~;onance spectroscopy was used to check both protonation and 
complexation of the PCUA. The protonation of the ligand was evidenced by a shift in 
NMR signal arising from protons attached to neighbouring carbons and, also 
broadening and shifting of the peaks on complexation with copper(Il). 
The blood plasma sinulation studies using ECCLES (Evaluation of Constituent 
Concentrations in Large Equilibrium Systems) computer model showed that PCUA 
had a reasonable potential to mobilize copper in vivo. Zinc(II) and calcium(II) were 
found to be competilors of copper(Il) in blood plasma. The plasma mobilizing index 
obtained for copper-PCUA system was low for an effective mobilization of copper in 
the presence of othe'low molecular mass species in blood plasma. 
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1. INTRODUCTION 
1.1 RHEUMATOID ARTHRITIS 
Rheumatoid Arthritis (RA) is a chronic, inflammatory, systemic disease characterized by 
joint pain and swelling, joint destruction and pannus formation. L2 It is the most common 
inflammatory arthritis affecting about one percent of the general population worldwide.3 
RA is one of many chronic diseases that predominate in women. For instance, it has been 
reported that RA affects 2.1 million Americans and 1.5 million women have RA 
compared to 600 000 :nen.H Onset is usually in the middle age but often in ages of 20's 
and 30's. The reason jar this disease prevalence among women is unknown but 
presumably it is related to the hormonal milieu. 3-5 
RA remains a major medical challenge because the exact cause of the disease is still not 
known. However, it is known that RA is an autoimmune disease. l The body's natural 
immune system does not operate as it should resulting in the immune system attacking 
healthy joint tissue and causing inflammation and subsequent joint damage. 
Although RA is properly considered a disease of the joint, it is important to recognize 
that it can exhibit a variety of extra-articular manifestations.6 These manifestations 
clearly show that RAlas features of systemic disease capable of involving a variety of 
major organ systems such as lungs, blood vessels, heart or cyes. Histological studies 
show that within the ncumatoid synovium, there is hyperplasia of synovial lining cells 
and development of an intensive network of new blood vessels. 3 
Since the specific pathogenic mechanism of RA is poorly understood, the diagnosis is 
based upon clinical mmifestations or findings. The first indication of this disease is 
usually polyarthritis a+recting the small joints of the hands and feet in a systemic fashion. 
Large joints and cervi . .:al spine may also be involved but the thoracic and lumbar spine 
are usually spared. The diagnosis may be confirmed by the presence of subcutaneous 
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rheumatoid nodules, ry radiologic demonstration and detection of an antibody in the 
serum called rheumatoid factor. 6 
1.2 DRUG THERAPY FOR RA 
RA is a disease with increased mortality and signiticant morbidity for which effective 
therapy interventions are clearly needed.3 The uses of drug therapy for this disease are the 
relief of pain, the inhibition of inflammation and the restoration of normal immune 
mechanisms.7 
Highly effective drug treatments exist but early treatment is critical for relief of pain, 
reducing inflammatie,n, stopping or slowing joint damage, and improving patient function 
and wellbeing. Medications can be divided into two groups: symptomatic and disease 
modifying drugs. 
1.2.1 Symptomatic Drugs 
These medications are nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, 
analgesics, and glucocorticoids. These drugs help reduce joint pain, stiffness and 
swelling. 
NSAIDs remain an important part of the treatment ofRA. They influence pain and 
inflammation in RA but do not modify the progression of the disease.8 The traditional 
example of NSAIDs drugs are Ibuprofen and Diclofenac sodium. The dosage is 1,200 to 
3.200 milligrams per day in 3 or 4 doses and 100 to 200 milligrams per day in 2 or 3 
doses respectively. Although NSAIDs are effective fighters of both pain and 
inflammation, gastrointestinal side effects have become the most important complication 
of chronic therapy with NSAIDs. A number of adverse reactions involving the kidneys 
has also been associated with the use ofNSAIDs.3 
2 
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Because ulcers are potentially dangerous side effect ofNSAIDs use, a new option of 
NSAIDs was recently brought to the market. These are called Cyclooxygenase-2 (COX-
2) inhibitors and are slfe to the stomach. Although the traditional NSAIDs and COX-2 
inhibitors are used, aspirin remains the premier salicylate to be used as an option because 
of its low cost and potency. 
Analgesics play an important role in the treatment of RA. They are mainly for pain relief 
and are used for patients with mild or intermittent symptoms who do not need regular 
therapy. One of the mJst commonly used analgesics is acetaminophen. Unlike NSAIDs, 
acetaminophen and other pure analgesics do not relieve inflammation. The dosage is 325 
to 1000 milligrams every 4 to 6 hours as needed but no more than 4 000 milligrams per 
day.9 
Glucocorticoids are also symptomatic medicines. They are sometimes referred to as 
corticosteroids or simply steroids. Glucocorticoids make up one of the oldest and most 
commonly used categl)ries of drugs for arthritis. The dramatic effects of cortisone and 
adrenocorticotropic hormone (ACTH) on the signs and symptoms of active RA were first 
reported by Dr. Hencl- and his associates in 1949.3. 10 For many symptomatic rheumatic 
diseases, these drugs ~imply work too well yet have too many side effects. The most 
feared complications in patients with RA have been the effects of steroids on bone and 
gastrointestinal tract. 3 
1.2.2 Disease Modif) ing Drugs 
The second category cf drugs which apparently affect the rheumatoid disease process are 
disease modifying drugs. These include low doses of methotrexate, leflunomide, 
D-penicillamine, sulfasalazine, gold therapy, minocycline, azathioprine, 
hydroxychloroquine (and other antimalarials), cyclosporine and biologic agents. These 
medications can be further divided into two: disease modifying antirheumatic drugs 
(DMARDs) and biologic agents. 
3 
Un
iv
rsi
ty 
of 
Ca
pe
 To
wn
DMARDs actually stop disease progression before it can cause irreparable joint damage. 
While DMARDs are powerful arthritis fighters, an instant result should not expected, 
hence they are also called slow acting antirheumatic drugs ( SAARDs).lO 
A widely used and effective DMARDs, which was specifically developed for RA is 
leflunomide (Arava). Others were approved for RA only after years of use for other 
purposes. For example, cycloporine was used to prevent organ rejection in people who 
had undergone transplants. Hydroxychloroquine sulfate was used to treat malaria and 
methotrexate, one of the most widely used and effective drugs for RA, original used for 
cancer treatment. People with moderate to severe RA who have not responded well to 
DMARDs may opt to try protein-A immunoadsorption (Prosorba) therapy. 
1.3 METAL IONS AND CHELATING AGENTS IN MEDICINE 
Metal ions playa vitd role in a vast number of widely differing biological processes. 
These processes are quite specific in their metal ion requirements such that certain metal 
ions in specific oxidation states fulfill the necessary catalytic or structural requirements. 
Metal ion dependent processes are found throughout the life sciences and vary 
tremendously in their function and complexity.14 
The concentrations 0 the naturally occurring metal ions in living systems are carefully 
controlled within fine limits. The interrelationships between metal ions and binding 
substances in the body are so complex that disorders or disease involving the metal 
binding substances may result in the presence of high or low concentrations of metal ions 
compared with that normally present. A number of major diseases are associated with 
changes in concentraion of the trace metal ions in certain tissues and body fluids. It 
appears that the role of metal ions in medicine can be considered for the following; a). 
metal poisoning, where excess metal is ingested, b). abnormalities resulting from 
breakdown of the body's own control system or failure of the metal ion control system 
and c). the diagnostic analysis of metal ions in the body tissues and fluids. 
4 
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A trace metal ion that is essential for activity of enzyme systems may be well become 
toxic if the concentral ion is raised above certain limits. For example, doubling of the 
extracellular concentration of potassium ion leads to heart disorders and possibly death. 
On the other hand acc umulation of copper in the tissues, particularly in the liver, brain 
and kidneys is a result of Wilson's disease. The symptoms may be controlled by 
penicillamine. Of the metal ions that have been examined, copper appears to be the most 
valuable pointer to di.,ease conditions. For infectious hepatitis, serum copper levels rise 
up to three times the normal value due to an accumulation of ceruloplasmin. Other 
diseases associated with high copper concentrations in the blood are leukaemia, 
lymphomas, rheumatoid arthritis, psoriasis, cirrhosis, rephritis and 
Hodgkins's disease. 13 -1? 
The medicinal aspect, of many drugs act via chelation of metal ions. In general drugs act 
by controlling the action of cells, particularly nerve and muscle cells, by acting on 
subcellular structures or disturbing enzyme behaviour. The approach in this study is 
based on the design of copper complexes as anti-inflammatory drug from a bio-inorganic 
perspective. 
5 
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2. BACKGROUND TO STUDY 
2.1 COPPER A'lD RHEUMATOID ARTHRITIS 
As an essential clement, copper plays an important role in all organisms including 
man. Biologically active oxidation states of copper are (I), (II) and (III). These 
oxidation states are found in copper complexes that act to transport copper to body 
sites where it is required. The body gets copper from dietary sources and the richest 
dietary sources o'~ copper are animal liver, crustacea, shell fish, dried fruits, nuts and 
chocolate. 1 
Dietary copper is readily absorbed in the stomach and small intestine, from where it is 
transported to the liver by the blood as a serum albumin complex. In the liver, which 
is the principal copper processing organ, it is stored as metallothionin complex or 
converted into ceruloplasmin which is released into the blood to meet normal 
metabolic needs. Excess copper is excreted via the bile where it is complexed to 
bilirubin, thereby preventing reabsorption in the gut. 2--+ 
Copper is required for haemoglobin synthesis, keratinisation, pigmentation, bone 
formation, reprocLUction, fertility, development of central and peripheral nervous 
systems, cardiac function, cellular respiration, nerve function, extracellular 
connective tissue formation and regulation of monoamine concentration.5 Tissue 
requirements for copper are believed to be met and controlled in a homeostatic 
fllshion based upon availability, absorption, storage, utilization and excretion.5 All 
normal tissues contain copper in the form of copper dependent components which 
include metallo-proteins, metallo-enzymes and lower molecular weight complexes of 
biological importance.2-5 
Copper complexes were observed to be effective in the treatment of rheumatoid 
arthritis and othe" degenerative connective tissue diseases as early as 1941.5•21 The 
elevated serum copper levels during Ri\, and anti-arthritic properties of copper 
8 
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compounds led tc. the hypothesis that endogenous copper might have a protective 
function in chronic inflammatory conditions. The former copper compounds used in 
the drugs were clpralene, [Cu(I) (3-allylthiouredobenzoate)] and [Cu(II) 8-
hydroxyquinoline (diethylammonium sulphonate2)] also known as dicuprene. Besides 
these, another tre;ltment of RA was by wearing copper bracelets. It was observed that 
through sweat, bracelets were solubilised and promoted dermal absorption of copper 
into the blood stn;am.6 The discovery brought about many articles in the literature 
indicating that copper complexes can be effective in the alleviation of inflammation 
associated with RA. The search for less expensive, more effective and safer therapies 
for this disease, and or inflammation associated with it remains a challenge. 
2.2 MECHANISMS OF ANTI-INFLAMMATORY COPPER COMPLEXES 5·7 
Important gains have been made concerning possible biochemical mechanisms of 
action for copper complexes in relieving inflammation. The possible mechanisms are 
induction of lysyl oxidase, modulation of prostaglandin synthesis, induction of 
superoxide dismlltase or superoxide dismutase mimic activity, stabilization of 
lysosomal membranes and modulation of the activity of histamine. 
a). Induction of Lysyl Oxidase 
Lysyl Oxidase is a copper dependent enzyme responsible for repair of damaged 
tissues due to inflammation. The process requires cross-linking and extracellular 
maturation of the connective tissue components, collagen and elastin. It has been 
observed that lys~'l oxidase activity is induced in copper deficient chickens with 
copper(II) sulpha1 e. 
9 
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b). Modulation of Prostaglandin Synthesis 
Copper complexes have been shown to decrease the synthesis of the pro-
inflammatory (vasodilator) prostaglandin, PGE2 and a concomitant increase in the 
synthesis of the alti-inflammatory prostaglandin (vasoconstrictor), PGF2u. 
c). Induction of Superoxide Dismutase and Superoxide Dismutase Mimitic 
Activity 
Rheumatoid Arthritis has been associated with deficiency or lack of superoxide 
dismutase enzyme activity. The human superoxide dismutase contains copper at the 
active site and is required for its dismutase activity. The superoxide anion which 
initiates inflammation, is disproportionated by this enzyme. 
d). Stabilization of Lysosomal Membranes 
Copper is also found to be important for redox control of human synoviallysosomes. 
The synovial fluid contains lysosomal enzymes which are destructive towards 
cartilage. The permeability of lysosomes is found to be decreased by copper and in 
addition decreasec the ratio of free versus bound lysosomal enzymes. 
e). Modulation of the Activity of Histamine 
Modulation of the physiological effects of histamine may also be an important 
biochemical role for copper complexes. It is found that copper-histamine complexes 
are the active form of histamine. 
2.3 COMPUTER-BASED APPROACH 
The concentration .)f low molecular weight transition metal complexes is usually very 
low. These complexes are of immense biological significance because they perform 
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many roles. They an~ involved in the transport of metal ions across membrane and 
between biological binding sites. However, their biological role is not easy to 
elucidate because th~y exist \vell below the limits of analytical means of detection. 
They are also not amenable to isolation and concentration techniques because these 
would upset the labile equilibria in which they participate.s 
A computer simulation of the equilibrium reactions between transition metal ions and 
low molecular weight ligands was considered to be the only reliable way to determine 
which of the thousa1ds of possible complexes would be important under biological 
conditions. Comput~r simulation in this regard is the calculation of the equilibrium 
concentrations of the individual species formed in the solutions of metal ions and 
ligands. It requires lhe thermodynamic formation constants for all the complexes 
present in the mixture and the overall concentrations of the components. The 
computer program called ECCLES, (Evaluation of Constituent Concentrations in 
Large Equilibrium ~~ystems) was developed to permit the simulation oflarge and 
comprehensive systems.22 
In simulation of da1a concentration scans are done to ensure that the imposed free 
concentrations of the metals do not influence their distribution among low molecular 
weight ligands.9 In the free metal concentration range that was scanned, the extent of 
complexation of 100v molecular weight ligands is far greater than total concentration 
of metal ligand complexes. This is because of the very low total concentration of the 
transition metals, the weak bonding abilities of calcium(II) and magnesium(II) and 
the decrease in metal ion concentration due to protein binding. However, the problem 
arising from inclusion of protein binding constant in computer simulated blood 
models are avoided. Computer modeling using ECCLES has provided evidence in 
support of the hypothesis that the administration of low molecular weight copper 
complexes would be beneficial in the treatment ofRA.9• 11 
The use of chelatir g drugs to displace the labile copper equilibrium away from 
plasma albumin in favour of the tissues is the most straight forward way of utilizing 
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endogenous copper reserves. For this to occur, it requires a drug which is able to 
compete effectively with the protein for the metal ion and that the predominant metal 
complex formed in plasma should readily diffuse into the affected synovial tissue. 
The extent to which administered therapeuticals may be able to fulfil these conditions 
can be judged by simulating their effects in plasma using ECCLES. In particular a 
function called Plasma Mobilising Index (P.M.!) is used to ascertain whether the 
agent is sufficiently powerful and copper specific. Drugs that successfully bind 
copper in vivo in thE' presence of competing endogenous ligands produce large P.M.! 
values, which for c('pper are calculated as follows; 12 
(P.M.I)cu 
Total low molecular weight Cu(II) 
concentration in plasma in presence 
of the drug 
Total low molecular weight eu(II) 
concentration in normal plasma 
Based upon the above information, several investigations were carried out by 
researchers to furth~r the use of copper complexes in alleviation of inflammation and, 
orRA. 
2.4 DESIGNING COPPER(II) COMPLEXES AS ANTI-INFLAMMATORY 
AGENTS 
The ab initio design of therapeutic agents usually depends on a knowledge of the 
difference between health and disease at a molecular level. 8 Although the causes of 
RA are not yet known, the observed effect of copper on inflammation find the 
mechanism in which can be utilized in the meantime. Of importance is to find a 
mechanism in which the supply of copper can be increased at the sites of injury. 
The design of RA agents which reduce inflammation is based upon the assumptions 
that a). the therapeutic effect of copper administration arises from increase in the total 
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labile copper concentration in the body compariments such as synovial fluid and b). 
the increase is due to the formation of complexes in plasma that can ditIuse into 
synovial fluid through the separating membrane. 
In order to successfully administer and mobilize the metal ion in the body fluids, 
several general requirements have to be fulfilled. In this case ligands can be used 
either to mobilize copper from endogenous reserves or exogenous sources, thereby 
increasing the low molecular mass fraction of copper complexes in the body fluids. 
The following features would be desirable in a drug design: 13.14 
a). The ligand concerned must be a strong copper complexer in order to form 
thermodynamically stable species with the metal ion at physiological conditions. 
b). The ligand should contain predominantly nitrogen donor groups for high 
selectivity to copper and that other metal ion equilibria, such as calcium or zinc, are 
not disturbed in their essential body function. 
c). The complex formed must be kinetically labile to be able to liberate and release 
metal ion at the biologically active site. 
d). The complex formed must be formally uncharged and also be lipophilic to enable 
transport across ceJl membranes. 
e). If the complex is to be administered orally, it ought to have a reasonable low acid 
dissociation constant so that it can be in an uncharged form at intestinal pH values. 
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Figure 2.1: Routes for i11creasing the concentration ofl.m.w. copper complexes in blood 
Plasma.s 
The increase in the (ocal concentration of copper complexes may be achieved by the 
two general routes as illustrated in figure 1.8 One is based on the liberation of 
endogenous reserves while the other on copper supplementation by oral or topical 
administration. For short term therapy endogenous rather than exogenous sources 
seem appropriate. 1 his can be achieved by a) equilibrium competition for the labile 
protein-bound copper, b) decreasing the affinity of serum albumin for copper by 
allosteric effects an.:i c) extracting copper from inert metalloproteins. 
Several ligands have been investigated with copper in trying to fulfill the mentioned 
requirements. It was found that the copper mobilizing efficiency of a ligand increases 
as the donor atoms changes from 0 to S to N. l5 Since the thiol group is toxic, it is not 
favourable for human therapeutic compounds. Reports show that as the number of 
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donor atoms in the ligand increases, stability of copper complexes should 
increase. 18,23 It is als·) observed that the stability of inorganic chelate complexes is 
affected by the size of the chelate rings formed upon coordination. For example, 5,6,5 
membered chelate s~'stem is more stable than 5,5,5 membered chelate system. 16,17.23 
Further investigations were done for 3,6,9, 12-tetra-azatetradecanedioic acid (Ttda) 
and 3,6,9-triazaundecanedioic acid COtda). These ligands formed neutral complexes 
but were found to be highly hydrophilic and easily excreted in urine despite being 
formally uncharged. 18 The neutrality of the copper complex was achieved by 
incorporating two acetate groups on the ligand. 
In order to increase the lipophilicity of the complex, it was further decided to bury the 
charge within the ligand. This was achieved by using amides which upon metal 
coordination lose their protons. The ligands KN-bis[2-(dimethylamino)ethyl] ethane 
diamine, (SUM); N.N-bis[2-(dimethylamino)ethyIJ propane diamide, (6UM) and 
N ,N-bis [2-( dimethylamino )propyl] ethane diamide were investigated. 14.16 It was 
found that the copp,;r complexes of these ligands were not neutral at physiological 
pH. The plasma mobilizing index curves of these ligands showed that these ligands 
are unable to compete with endogenous ligands hence are poor at mobilizing 
copper. 19 
The research contirued by investigating a series of penta-nitrogen donor ligands. This 
was done in order t) increase both stability and lipophilicity of the complexes. It was 
found that penta-nirogen ligands indeed formed more stable complexes than their 
tetra-nitrogen analoques. 19,20 
The present study is an investigation of a tetra-nitrogen donor ligand system. It has 
two amino groups and also two amides which upon metal coordination are expected 
to lose their protons. This system is similar to that studied by Voye. 14,16 The structure 
of the ligand 3,5-b,S[ (arninoethyl)ethanediamide ]-4-oxahexacyc1ododecane (PCUA) 
at hand is shown in figure 2.2. 
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The complex formee is expected to be stable in solution. Of interest in this ligand is 
the cage moiety attached at the top. This would increase complex Iipophilicity and 
dermal absorption of copper. In addition, the chirality and rigidity of the cage should 
impose some interesting properties on the ligand. 
Hl "'0 Glycine 
H2d 
PCUA 
Figure 2.2: Structure:; of PCUA and glycine ligands. 
2.5 OBJECTIVES OF THIS STUDY 
In order to contribute to the understanding of drug design in the mobilization of 
copper(II) at the sitf of inflammation, the thesis had the objectives. 
Determination of the protonation constants of PCUA and the 
thermodynamic stability constants of this complex with copper(II), 
zinc(II) and calcium(II) in aqueous solution using glass electrode 
potentiometry. 
Determination of the structures of the copper complex species using 
UV Ivisible spectrophotometry and nuclear magnetic resonance studies. 
Determination of copper plasma mobilizing index for PCUA. 
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3. GLASS ELECTRODE POTENTIOMETRY 
3.1 THEORY 
3.1.1 Introduction 
Potentiometry is one of the most convenient and successful techniques employed for 
metal complex equilibrium measurements. l Potentiometric methods embrace two major 
types of analyses. One involves the direct measurement of an electrode potential from 
which the activity (or concentration) of an active ion may be derived. The other type 
involves measuring the changes in the electromotive force (emf) brought about by the 
addition of a titrant to the sample.2 Analytical chemists design electrodes whose 
potentials vary in response to changes in the concentration of a specific analyte in 
solution or in the gas phase.3 
Glass Electrode Potentiometry CGEP) has found a significant place in the study of many 
chemical systems in biological, medical and environmental studies.4 GEP being one of 
the oldest instrumental methods of analysis, has for the past four decades expanded 
tremendously. I It is preferred because of its high sensitivity, its non-invasiveness and its 
easy accessibility. However, enhancement in the accuracy and predictability of the values 
arising from glass electrode potentiometry require a full mastery of the principles behind 
electrode calibrations.4 
The easy availability of a glass electrode, its linear Nemstian response, rapid reversibility 
and high sensitivity to aqueous hydrogen ions over a wide concentration range makes it a 
suitable technique for the study of equilibria. The classic electrode assembly consists of a 
pH-indicating electrode and a reference electrode. Typical pH-sensitive glass membranes 
are either sodium/calcium silicate or lithium silicates with lanthanum and barium ions, 
which act as lattice tighteners to retard silicate hydrolysis and lessen alkali ion, chiefly 
sodium ion mobility. The conventional pH electrode has an internal reference electrode 
(silver/silver chloride or calomel) immersed in a chloride salt buffer (usually a phosphate 
19 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
at pH 7) solution, with glass membrane separating it from the test solution. The body of 
the glass electrode is a nonconducting glass tube sealed to a bulb made of special 
conductive glass which is the pH sensing membrane. The body is filled with a buffered 
electrolyte of fixed pH value and ionic concentration. This design assures that constant 
potentials are developed on the inner surface of the glass membrane and on the internal 
reference element. 2 
In the determination of ligand protonation constants, the ligand solution depending on the 
initial pH, is titrated with either acid or base in such a way that the pH range of 2 to 11 is 
scanned. By the inclusion of the metal ion in such a titration, stability constants may upon 
data analysis, be found. 
3.1.2 The Stability Constant 
For simplicity, the term "stability constant" or "formation constant" will in this study 
refer to the values obtained for the overall formation constant of a metal-ligand species. 
The stability constants provide a quantitative measure of the extent to which a metal will 
complex with a particular group or ligand. The chemical association of a ligand with 
protons will then be refe rred to as the protonation constant. 5 
The position of equilibrium and hence the numerical value of the reported stabibility 
constant when expressed in concentration units, is normally dependent upon the 
temperature and the nature of the medium especially the solvent and ionic strength.6 For 
any single chemical system studied under a particular set of conditions, different workers 
may report a range of stability constant values. A set of stability constants may be 
comparable if they have been measured under similar experimental conditions. 
The most accurate and reliable method for the determination of stability constants 
potentiometrically is to ti lrate one solution (acid or alkali) with another (of constant total 
metal and total ligand with alkali or acid), with the potential being determined after each 
addition of titrant. 7 The slUdy of stability constants essentially involves competition 
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between two metal ions of which one may be H'. However, the base titration of aqueous 
metal-ligand equilibriH involves competition between the water molecules, the ligand 
molecules and hydroxide ions for the metal. The ligand donor sites also attract hydronium 
ions and metal ions. I There may be several pre-complexation processes involved before 
the final complex species. These would include loss of a coordinated water molecule 
from the metal, followed by coordination to the ligand molecule accompanied by loss of 
proton. The overall stability constant is actually the product of stepwise stability 
constants. However, the constants of the predominant chemical product species are 
selected to constitute tne model that best describes the chemical system. 
It is clearly of great importance to be able to assess the factors that influence complex 
stability. 5 These factors or criteria can be used for the selection of a ligand donor atom for 
binding of a certain metal ion. Pearson's HSAB (hard and soft acids and bases) principle 
may be used for the choice of ligand donor atom. According to this theory, a hard donor 
atom will prefer to bond to a hard accepter atom. If a range of complexes formed by one 
metal ion is known, Irving-Williams series (Mg<Mn<Fe<Co<Ni<Cu>Zn) may be used to 
predict the strength of complexes formed by another metal ion in the same series.s The 
known coordination sphere of a metal can also assist in postulating the kind of species 
that a ligand of a particular denticity will likely form with metal ion, which will also 
determine the extent to which the complex will be aquated. The concentration ratios of 
the reactants also influence the species that may predominate at equilibrium.5.68 A high 
metal to ligand ratio may result in polynuclear species. 
The chemical reaction between metal ion M and a ligand L at equilibrium may be 
represented as; 
M + L + H <=> MLH .. 3.1 
Depending on the available parameters pertinent to the system, the stability constant ~, 
may be defined in thre~ ways, thermodynamic, stoichiometric or mixed. It is said to be 
thermodynamic when \'~xpressed with respect to the activity of the reacting species; 
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or stoichiometric when expressed with respect to the concentration of the reactants; 
P\!LH = [MLH] I [M][L[H] 
It is can also be described as mixed if it is expressed with respect to both the 
concentration and the ;:.ctivity coefficients interchangeably; 
f3\1LH = [MLH] / [M] [L ]aH 
.. 3.2 
.. 3.3 
.. 3.4 
The ideal thermodynamic stability constant is determined only at an ionic strength equal 
to zero (I = 0), but this is practically impossible because the reactants species themselves 
make ionic contribution to the reactant solution. 1,4 It is therefore necessary to measure 
stability constants at specified constant ionic strength so that comparison can be made 
when working under similar experimental conditions. It is from this specified constant 
ionic strength that extrapolation is made to zero ionic strength to obtain thermodynamic 
stability constants. In this study experimental conditions refer to the ionic strength (1), the 
temperature (T) and th\: nature of the background electrolyte. 
3.1.3 The Background Medium and Temperature 
Whole body investigatlons must, of necessity be performed in a nutrient medium that 
supports the life of the organism.6 However, it is also necessary for a solution chemist to 
choose working medium conditions for the chemical model. In order to determine 
stability constants at constant ionic strength, several salts are used for the test solution. 
These include potassium nitrate (KN03), sodium perchlorate (NaCI04), sodium chloride 
(NaCl), and potassium chloride (KCt). The concept of ionic strength was introduced in 
1921 by Lewis and Randall who stated that, 'in dilute solutions, the activity coefficient of 
a given strong electrolyte is the same in all solutions of the same ionic strength,.9 It was 
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since then that many v.orkers attempted to keep activity coefficient constant by using 
solution of constant ionic strength. For a given chemical system, the background 
electrolyte is selected ~uch that it a) contributes little to the measured physical property, 
b) forms very weak complexes with the species under investigation and c) is sufficiently 
soluble in the solvent lised to give ionic medium of the required concentration. 
It is desirable to select the electrolyte that yields ions that are common to the reacting 
acid and base. Basically the anions of the electrolytes are the ones employed to maintain 
the ionic strength at a constant value. Among the anions of interest, chloride ion has a 
tendency to form ion pairs. The trend in the tendency to form ion pairs is as follows; 8 
However, it was found that a trend in series of stability constants measured in 3.00 M 
NaCl04 had values similar to the trend in stability constants measured in 0.15 M NaCI. 
Therefore, sodium perchlorate is used as a background electrolyte in studying biological 
systems. In this study sodium chloride would be preferred because human blood is 
isotonic with 0.15 M :t\aCI. The other reason is that CI04" has been found to induce 
problems to the electrode thus resulting in consequential serious impairment in its 
performance and increasing drift. I 
The activity a of the ion is defined with respect to its activity coefficient yand 
concentration c as follc1ws; 
.. 3.5 
The ionic strength I of a solution is defined by the expression; 
.. 3.6 
where c and z are the concentration and the charge of the ion i respectively. 
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The stability constants are also affected by temperature as represented by the Van't Hoff 
equation; 
.. 3.7 
where ~Ho is the standard enthalpy change of reaction and is related to Gibbs free energy 
~Go and entropy ~SO changes of reaction, T is the absolute temperature in Kelvin and R is 
the natural gas constan': in JK-Imor l . 
3.1.4 The Electrode Cell and Glass pH Electrode 
In a potentiometric typ<= of sensor, a membrane or sensing surface acts as a half cell, 
generating a potential proportional to the logarithm of the analyte activity 
(concentration). This potential is measured relative to an inert reference electrode that is 
also in contact with the sample or test solution.2 From the reaction cell, the observed 
potential is due to the rotential difference between the glass electrode and the reference 
electrode Ere!", the potential of the liquid junction of the reference electrode Ell and the 
potential at the membrane of the glass electrode 
represented by the following equation; 
The reaction cell potential may be 
.. 3.8 
The potential of the glass electrode may be written in terms of the activity of hydrogen 
ion to which it is responding by means of the Nernst equation; 
0+ (RT/F)ln{H} .. 3.9 
where F is Faraday constant, T is the temperature of the system, R is the gas constant, 
is the standard electrod~ potential and {H+} is the activity of hydrogen ion. 
24 
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The cell potential may be rewritten as follows; 
=: [EgO + (RT/F)ln:Hr}]-
.. 3.10 
The glass electrode potentiometry employs glass pH electrode which measures the 
concentration of the hydrogen ions at constant ionic strength. The activity of hydrogen 
ions becomes a constant at constant ionic strength. Since the concentration of the 
hydrogen ions is a meamrable quantity, the cell potential can be defined by the 
relationship; 
Ecell = Econst + (RT/F)ln,HT] 
where RTfF is the S"emstian electrode response slope and Econst is a potential dependent 
on the electrode system used.4•'o 
Shielded 
hlQh ~ insuiotion. 
CObi' __ 
High*insulation 
stem) preferob I ( 
shielded_ 
------
Inner reference 
electrode 
(e.g., Ag-AQC~) 
Inner 
buffer solulion 
Responsive 910;5 
KCIt-colomel 
reference electrode 
Mercury 
KCJ(-colomei 
Salt bridge 
solut [on 
(e.g., 3.5 M KC~] 
Liquid junction 
(e.g., ceramic plug] 
Figure 3.1: Glass indicatcr - calomel reference electrode cell with liquid junction. IO 
The glass electrode system for potentiometric determination of stability constants is 
shown in tigure 3.1. 10 The glass pH electrode has several constructional components 
25 
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which are contributors to the overall glass electrode potential. Such components include 
the inner reference electrode, the inner glass surface, the outer glass surface and 
asymmetric characteristic of the glass such that a potential may exist across it even when 
identical solutions are in contact with the inner and outer surfaces. The inner solution 
which forms part of the inner reference electrode system, is used to provide a stable pH to 
ensure a constant potential on the inside of the glass. The temperature dependence of the 
potential response for hydrogen ion activity (concentration) is demonstrated by the slope 
factor, s, in the Nernst equation; 
.. 3.12 
The reference electrode is an oxidation/reduction half cell of known and constant 
potential at a particular temperature.2 It consists of three principal parts which are an 
internal element, some filling solution which constitutes the salt-bridge electrolyte and an 
area in the tip of the electrode that permits a slow, controlled flow oftllling solution to 
escape the electrode caled the fluid or liquid junction into the sample. The liquid 
junction potential at this boundary is considered to arise because of differences in the 
mobilities of ions carrying opposite charges. It is said to constitute one of the most 
important and difficult parts of electrochemical measurements with the glass electrode at 
both theoretical and pntctical standpoints. The liquid junction potential may be affected 
by; 
pH and ionic m)bility 
ionic strength 
colloids and su~pensions 
non aqueous aqueous boundaries 
the salt bridge solution 
temperature ancl pressure. 
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3.1.5 The Basic Equilibrium Systems Equations 
The reaction between metal ion, M, and n ligands, L, may be represented with their 
stepwise equilibrium st..lbility constants as follows; 
M + L <=> ML ~l [ML] / [M] [LJ Kl 
M + nL <=> MLn 
where K's are called th~ stepwise stability constants and Ws are called the overall 
constants.6 
F or a equilibrium system which involves protons, , equation 3.13 becomes: 
M + L + H <=> MLH ~MLH = [MLH] ! [M] [LJ [H] 
However, if the hydroxide ion OH- emerges in the system then the above equation 
becomes; 
M + L + OH <=> ML(OH) ~ML(OH) = [ML(OH)] I [M] [L] [OH] 
.. 3.13 
.. 3.14 
.. 3.15 
.. 3.16 
In data analysis, the loss of proton from a metal complex is viewed as similar to the gain 
of hydroxide ion; 
M + L <=> MLRI H ~MLH-l [MLR1] [H] / [M] [L] .. 3.17 
A comparison of equations 3.16 and 3.17 reveals that the equilibrium constants defined 
by these two equations may be related to the ionic product of water; 11 
~~ILH-I = ~\ILlOH) [H] [OH] ~MLlOlll Kw .. 3.18 
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therefore; log~\'Ll'_' = log~ML(OH) pKw .. 3.19 
3.1.6 Computational nata Analysis Theory 
The employment of computational analysis comes after the data have been carefully 
collected in the laboratc'ry. It is then that the unknown parameters are calculated from the 
accurately measured and known parameters. In this case the unknown parameter of 
interest is the stability constant. The known parameters may include volumes of reaction 
solutions, temperature, potential existing in the solution and other parameters. 
In a solution of constan1 ionic strength containing metal ions. M, ligands, L, and protons, 
H+, a general equilibrium reaction can take place as described by mass balance 
. 11 P 
equatIOn; --
.. 3.20 
where p, q and r are the stoichiometries of the components in the complex. 
The equilibrium constant, ~pqr, for this reaction is designated as; 
.. 3.21 
where [] denotes concentration of species. 
The total concentration of the metal, T :VI, and of ligand, T L will be; 
.. 3.22 
.. 3.23 
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where [M] is the concentration of the free aquated metal ions and the summation is over 
the concentration of all the metal containing species which may be protonated (r > 0) or 
may not (r 0), and [L] is the concentration of the uncomplexed ligand and the 
summation is over the concentration of all the protonated and unprotonated ligand 
containing species. It is possible that r may be less than zero (r<O) in which case either a 
proton has been lost from the complex or an hydroxide ion has been added. 
In this study the species MpLqHr is denoted by the stoichiometric coefficients p,q,r i.e. 
11-1 denotes the compl(:x species MLRI with r 1 referring to the removal of a proton 
from either a coordinated ligand or a bound water molecule or hydroxide ion addition to 
I' 14 the complex.~' The MpLqHr can be regarded as protonated complex if r 2 1. 
The establishment and lhe use of mass balance equations ensures that all possible 
complex species of a s) stem under study are detected and hence their formation constants 
can be determined .. 
3.1.7 The ESTA (Equilibrium Simulation of Titration Analysis) Program Libraryl5 
The program EST A is a flexible, important computational tool for the determination of 
protonation and formation constants in aqueous chemical equilibria. The program library 
is used to calculate equilibrium distributions of chemical species, to analyse 
potentiometric titration data and to manipulate titration data for a variety of other 
purposes. The calculations are performed using a Gauss-Newton method to solve the 
mass balance equations (m.b.e). 
The Gauss-Newton method is used to minimize the objective function, U, in the ESTA 
program. The objective function is optimized by the task OBlE within the ESTA2 
module. The optimizatlon is done with respect to the observed emf (electromotive force). 
In contrast with the OBJT task, optimization is based on total concentrations. Since the 
variation in total concentrations are smaller than the variation in emf, OBJT is more 
robust and faster than OBJE but is less sensitive. Thus in practice OBlT would often be 
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used for initial optimization followed by OBJE for the final optimization. The EST A 
program also calculates two important functions which are the formation function, Z-bar, 
and the deprotonation function, Q-bar. These functions are calculated by the tasks ZBAR 
and QBAR within EST A 1 module. They are defined differently for the ligand, the binary 
and the ternary systems. This is because the kinds of equilibria taking place in the 
different systems may Yary depending on the number of the components that constitute 
each system. 
The program ESTA also incorporates the task SPEC in ESTAI module and this 
calculates the distribution of species taking part in an equilibrium system as a function of 
the pH of the solution. 
3.1.8 The Objective Function (U)16 
The objective function, U, may be described as the summation of all the squared residuals 
of the real parameter values from the calculated values. This function may represented as: 
DT = ("N )-1 "" -I "" (obs ca1c)2 np L.. ne L.. wnq Ynq Ynq 
where N is the total number of experimental points, 
np is the number of parameters being optimized, 
ne is the total number of electrodes, 
wnq is the weigh~. of the qth residual at the nih point and 
Y nq is the electrode emf of the electrode q at the nth point. 
.. 3.24 
The optimization of the resulting data can be achieved by minimization of the objective 
function. In order to mlnimize a Gauss-Newton approach is employed and this 
assumes that the function is quadratic with respect to all the parameters. Therefore U can 
be expressed as; 
.. 3.25 
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Where a and bare Gauss-Ne\\lton quadratic parameter vectors, p is optimization 
parameter vector, pt transpose of p and H, the Hessian, is given by: 
Rr = d2U I dPsdPr .. 3.26 
A well defined system with good initial estimates often converges. The calculations are 
terminated if the resultant shift vectors are large or if the shift vector has an upward 
gradient. Once the U is minimized, the standard deviation, the Hamilton R-factor and its 
limit and the correlation coefficients are then calculated and reported with the optimized 
values of the stability constants. 
3.1.9 The Formation Function (Z-bar) and Deprotonation Function (Q-bar) 
The EST A programs also calculate two important functions from the titration data. These 
functions are the formation function, Z-bar, and the deprotonation function, Q-bar. These 
functions are defined di tferently depending on the presence or absence of a metal ion. 
In the absence of a metal ion the protonation function is expressed as; 
.. 3.27 
where TH * is the total hydrogen ion concentration, T L is the total ligand concentration and 
OH = Kw / [H]. The ZH function is plotted against pH. The ZH may be described as the 
average number of hydrogen ions bound to the ligand at each pH. 
The complex formation function, Z!vb measures the average number of ligands bound per 
metal ion at each concentration of the ligand. This function, Z\b may be represented as; 
.. 3.28 
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where TL and T~I are total ligand and metal concentrations respectively, and [L] is the 
free-ligand concentration. TI is given by the equation below; 
The function, Z\I. is pitted against pL, i.e. -log[L]. 
On the other hand, the deprotonation function, Q~h is the average number of protons 
released from the ligand per metal ion as a result of complexation. 
.. 3.29 
..3.30 
where TH and T\I are the total proton and metal concentrations respectively, and TII* is the 
calculated total concentration of protons that would be necessary to give rise to the 
observed pH in the absence of the metal ions or rather if no complexation took place . 
. .3.31 
where [OH] K, / [H] and the summation is the over all protonated ligand species. 
In binary systems. a formation function representing the number of protons that would be 
on the ligand in the ab:;ence of the metal ion, is simultaneously defined as; 
.. 3.32 
The difference betwee1 nil and QM gives the number of protons on the complex. This can 
be represented as; 
r = ( q x nil ) - ( Q\I X P ) .. 3.33 
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where p and q are the slOichiometric coefficients of the metal and the ligand respectively. 
If p = q = 1, and nH = Q\.t, then r = ° and hence ML species stability constant is given by 
~ 110' For r < 0, it is either the deprotonation of the complex formed or the formation of the 
hydroxo species. 
Polynuclear complexes arise whenever there is a ligand capable of bonding to more than 
one metal ion. Such ligands include hydroxide, carboxylate etc., as well as multidentate 
ligands that may act in a bridging fashion. 
3.1.10 Data Error Analysis 
The determination of the protonation and stability constants requires minimal 
experimental errors. Th~ optimization of stability constants may be affected by the 
magnitude of random and systematic errors inherent in the system. Therefore a thorough 
examination of these er'ors has to be made. This may be done by studying a well known 
system for experimentally generated error, or by varying the reaction conditions for a 
particular system and observing its reproducibility. 
Random errors usually cancel each other out as the number of titration points increases as 
opposed to the systemalic errors. 
3.1.10.1 Weighting]7 
The neglect of weighting can undoubtedly have very detrimental consequences. The 
purpose of weighting is to reduce as much as possible the adverse influences of optimized 
parameters that arise be:ause errors in the values held constant during the calculation 
tend to propagate differ(~ntly at different points. To obtain unbiased results, the data ought 
to be weighted so that those points likely to be distorted most by the experimental error 
are correspondingly reduced in their effects on the optimized values of parameters. The 
weight may be describd as the reciprocal of the variance of the residual between the 
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observed and the calculated data. The weight of the qth residual at the nth titration point 
may be expressed as; 
. = [" f s:.( obs f calc) I <;:. ) 2 2 ] -I \\ nq £..; l u Ynq - } nq , up f crp .. 3.34 
where ynqobs and ynqCalC are observed and calculated variables of qth residual at nth point 
respectively. crp is the standard deviation in the parameter p to be optimized. 
If the initial estimates of the optimized parameters are good, an excellent set of weights 
based on the particular model chosen can be calculated. These weights may be then 
applied as constants in the subsequent optimization. 
After an optimization of the weighted data, the experimental and calculated values of the 
refined parameter are indicated by the Hamiltonian R-factor. It is represented as; 
R H - [ {T / " -I" . ( obs )2 ]0.5 f - ~ £..; ne £..; Wni ~ Yrll .. 3.35 
The R-factor is compared with the R-limit calculated from; 
R H-[N/" -I" ( ObS)2]0.5 inn- £..; ne £..; WI q Y nq .. 3.36 
The Rlim H is the best po ,sible R value based on the random error in the analytical data and 
the number of variable:;. Thus the closer Rt gets to Rlim" the better the agreement 
between the theoretical model and the experimental data. Howver, if R fH < Rlim H the 
model is within the maximum allowed experimental error.36 
Figure 3.2 on the next page shows a flow diagram for computational procedure employed 
for the determination of protonation and stability constants by using EST A library 
programs. 
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NO Is the electrode 
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YES 
Input prot::mationl-______ -t 
datli 
NO 
/ Input complexation,I-___ ---4""! 
data L..:::..;..:.::.....:.....,.. ____ ----l 
J~ ~~ 
Propose chemically acceptable 
models by inspection of tbe curves 
NO Is refinement successful and 
1-+---;;"";---"""",, are R .;. U sufficiently small? 
NO 
NO 
Calc. tbeoretical formation 
Choose final model according to criteria 
of lowest R. U and SDEV's, goodness of 
fit of tbe curves and simplicity 
YES 
YES 
YES 
YES 
Figure 3.2: Flow chart describing the procedure for the detennination of the protonation and 
complexation constants.:;6 
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3.2 EXPERIMENT A L 
Titrations were performed using a Metrohm 6.0222.100 Combined LL pH glass 
electrode. The slope of the electrode was calibrated in terms of hydrogen ion activity 
using buffer solutions d known pH and finally EO determined by strong acid - strong 
base titration at 25°C. The emf was monitored using a Radiometer PHM 84 Research pH 
meter. The reaction vessel was kept at a constant temperature of 25°C by circulating 
water from a thennostated water bath. Titrant, for example sodium hydroxide solution, 
was dispensed by the U3e of Metrohm 665 Dosimat piston burette. 
All titrations were performed under an inert condition of nitrogen. The nitrogen was 
purified by passing it through a series of gas bottles containing, 50% potassium 
hydroxide to remove carbon dioxide, Fieser's solution to remove oxygen, glass woo], 
distilled water and background electrolyte solution of ionic strength 0.15 mol/dm3 (Crl) 
to humidify the gas. 18 The potentiometric titration system was controlled and monitored 
through a computer. 
3.2.1 Preparation of Solutions 
All titration solutions were prepared from recrystallized NaCI as background electrolyte, 
at ionic strength of O. h mol/dm3 (Cr1). The choice for this ionic strength was based on 
the fact that human blood is isotonic with 0.15 M NaCl. Prior to preparation of these 
solutions, the NaCI wa~ dried in a dessicator for at least 24 hours. The solutions were 
prepared using glass distilled deionised water which has been boiled to remove dissolved 
carbon dioxide and kept in a container protected by a carbon dioxide trap. 
3.2.2 Preparation of Ligand Solution 
Solutions of ligand under study were prepared by dissolving accurately weighed samples 
of glycine and PCUA in the background electrolyte. The estimated concentrations of 
these solutions were ca lculated based on the mass of each of the two ligands. The 
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concentration of glycin!; solution was approximately 0.01 M and that of PCUA solution 
was approximately 0.0:: M. 
3.2.3 Stock Acid Solution (Hel) 
Acid solutions of HCI '"ere prepared to a concentration of 0.0 1 M from Merck ampoules 
(l.09973 Titrisol) in background electrolyte. The solutions were standardized against 
recrystallized sodium tetraborate decahydrate (borax), ~a2B4071OrhO.18 
3.2.4 Stock Base Solution (NaOH) 
The solutions of 0.1 M NaOH were prepared from Merck ampoules (1.09959 - Titrisol) 
in background electrolyte and also CO2 free environment to avoid CO2 contamination. 
These solutions were stored in bottles fitted with CO2 traps. Standardisation of these 
solutions was done against recrystallized potassium hydrogen phthalate. 18 The 0.1 M 
NaOH solutions prepared were further standardized against 0.01 M HCI solutions. This 
acid - base titrations w~re also used to check the carbonate content of the sodium 
hydroxide solution by the use of Gran method. 19 
3.2.5 Metal Ion Solutions 
It is very important that the concentrations of standard metal ion solution be as accurate 
as possible to ensure good data analysis. 0.02 mol/dm3 solutions of the divalent cations 
were prepared from CuCh'2H20, ZnCh and CaCh2H20 in the background electrolyte. 
These solutions were titrated against 0.0 I M standard solution of disodium salt of 
ethylenediamine tetraacetic acid using the standard methods. 18 Fast sulphon black F 
(FSB), solochrome bla<:k (SB) and methylthymol blue (MTB) indicators were used for 
h d " f C 7+ Z 2+ d C 2+ . . I t e etermmatIOn 0 l,e, n an a IOns respectIve y. 
A small amount ofHct was added to the metal ion solutions to prevent the hydrolysis of 
the metal ions. The aci:i concentration in the metal solution was determined by 
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potentiometric titration of 15 ml volume of the metal solution with 0.01 M HCI solution. 
The Gran method \vas llsed to analyze the data obtained. 19.20,21 The acid titration of the 
metal solution was pref.:rred over the base titration to avoid possible metal hydroxide 
formation. The formation of the metal hydroxide would give inaccurate concentration of 
hydrogen ions present in the metal ion solution. 
3.2.6 Calibration of Glass Electrode System 
Prior to calibration, the electrode was stored in 3 M potassium chloride (KCI) solution at 
25°C. In order to ensure good performance by the electrode, it was placed in acid 
solution and then base solution for approximately 20 minutes per solution. That was done 
to ensure sensitivity of the electrode at a wider range of pH from acid to alkaline regions. 
The slope of the combi led pH glass electrode was determined using commercially 
available butTer solutions of known pH. These buffer solutions were of pH 4.01, 7.01 and 
9.18 and the buffer line was obtained by plotting emf of each pH solution against the pH. 
The Nernstian slope of the buffer line gave the value ofs = 59.15 which was within the 
acceptable working range of 58.60 to 59.16 at 25°C. 
Final calibration of the electrode Econsl was made from strong acid strong base titrations 
at constant ionic strength ( I 0.15 mol/dm3 ) and temperature ( 25°C ). That was done 
in order to obtain more precise values of sand Econst by the introducing the titration data 
into EST A library programs. 
The calibration of the t~lass electrode was performed to suit the condition such as 
temperature and ionic strength. The slope factor s and the potential dependent on the 
electrode system Econst were always monitored. 
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3.2.7 Potentiometric Titrations 
The potentiometric titrations were all performed using a Radiometer PHM 84 pH meter 
and Metrohm Dosimat burette which were linked and controlled by a computer. The 
calibrated combined pI glass electrode of 3 M KCI internal filling solution was 
connected to the pH meter. During the titration, stirring was done using a Teflon 
magnetic stirrer bar wh Ie reaction solution was protected from intrusion of atmospheric 
oxygen and carbon dioxide by passing a continuous stream of pure nitrogen over it. All 
solution were prepared at constant ionic strength (I 0.15 mol/dm3 crl (Na +) ) and 
titrations were performed at 25°C. 
Before experimental tit cations were done, the strong acid - strong base titrations were 
done in order to calculate the value of the response intercept, EO and the value of 
dissociation constant of water, pKw. These titrations were also done to check the 
carbonate contamination in the base stock solution. The Gran plots were made to check 
carbonate contamination and the contamination was shown by curvature in the region of 
equivalence point. The two Gran functions used are given as; 192021 
.. 3.38 
¢' ::= ( Vo + Vi ) x 10PH .. 3.39 
where Vo is the initial I eaction vessel volume and Vi is the volume of added solution at 
the illl point of titration The pH values used in the Gran functions at each titration point 
were calculated using the equation; 
pH -( (E - Eo) Is) .. 3.40 
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3.2.8 Protonation Titrations 
After having determined the values of Eo and pK\\ through the acid - base titrations and 
calibration of the electrode, ligand protonation titrations were performed. An aliquot of 
the ligand solution was dispensed into the titration vessel by a piston burette. The 
standardized lICI solution was added to the vessel from another burette to ensure that the 
ligand was completely protonated. The minimum initial volume that was required to 
cover the electrode wa~; made with 0.15 mol/dm3 NaCl solution. This solution was then 
titrated against the standardized NaOH at temperature of25 0c. The data obtained 
consisted of the volul11<; of the titre (NaOH) added and the corresponding emf values of 
the system at each titration point. 
The concentration of the ligand in the reaction solution was determined using two Gran 
equations 3.38 and 3.39. Plots of Gran functions against the volume of the base added 
showed two different graphs. The point where ~ intersect the x-axis shows the end-point 
volume of the base for free acid titration while~' intersects the x-axis at the end-point 
volumes of the base indicates the volume of the base that was used to deprotonate the 
ligand. Then the concentration of the ligand was calculated by dividing the concentration 
of the acid associated with the ligand by the number of the ionizable protons. This 
concentration was more or less the same as that calculated from mass used. The 
concentration of the lipnd calculated using Gran plots was used as an input into EST A 
file template. 
Having determined the values of Eo and pKw, and the concentration of the ligand through 
Gran calculations, these were used as input data into EST A tile template for 
determination of the pl otonation constants. The task ZBAR with plot options 1 and 2 
yielded observed and calculated curves respectively. The curves did not completely 
overlap but optimization of the concentrations by task OBlE resulted in good agreement 
between the observed and calculated formation curves. The acid concentration and 
protonation constant values obtained as the output atter the optimization were then used 
for ZH plots. Several d fferent titrations were performed at difterent initial concentrations 
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of the ligand. The data analysis was aimed at obtaining a system that converged after 
fewer cycles and whose standard deviations of the optimized parameters were acceptable. 
3.2.9 Complexometric Titrations 
The procedure for comolexation was carried out the same way as that of protonation 
titrations but with initinl varying concentrations of solutions of the metal ions. The 
titrations were termina1ed at the first visual sign of precipitation. The titration data for 
each of the pairs of titrations carried out at different metal to ligand ratios were analyzed 
separately as pairs and then altogether as a bulk data. The input data in the EST A file 
included the protonation constants, the calculated concentrations of the metal, ligand and 
hydrogen ions, Eo, pK\\ and titration data. The constants for the hydrolysis of the metal 
ions were included in t1e computation and refinement of the formation constants?2 
For Copper(lI) hydrol) sis; 
Cu2+ + H20 ¢ Cu(OHt + H+; logK lO_1 = -7.87 
Cu2+ + 2H20 ¢ Cu(OHh + 2Ht; logK lO_2 -14.33 
2+ ~- + Cu + 4H20 ¢ CU(OH)44 4H; 10gKlO-4 -39.03 
For Zinc(II) hydrolysi~< 
Zn2- + H20 ¢ Zn(OH)+ + H+; 10gK lO_1 = -9.17 
,+ . + Zn~ + 2H20 ¢ Zn(OH)2 + 2H; IogK lO_2 -17.1 
Zn2+ + 3H20 ¢ Zn(OII»)- + 3~r-; 10gKlO_3 = -28.4 
Zn2+ 4H20 ¢ Zn(OH)}- + 4H+; logK 1o-4 = -40.7 
2Zn2+ + H20 ¢ Zn(OII)3+ + Hj-; 10gK2o- 1 = -8.9 
41 
.. 3.41 
.. 3.42 
.. 3.43 
. .3.44 
. .3.45 
.. 3.46 
.. 3.47 
.. 3.48 
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.. 3.50 
.. 3.51 
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For Ca1cium(II) hydrolysis; 
Ca2+ -I- H20 Ca(OH' -I- HT; logK1o_1 -12.7 .. 3.52 
The complex species a:1d their stability constants were determined using ESTA library of 
computer speciation mJdeling programs. The task BETA was used to evaluate the 
initially estimated eomplex species and their fonnation constants. The output of this task 
was introduced into the task OBlE within EST A2A module to give optimized values of 
the stability constants and the ligand concentration describing the system. 
Complex formation anJ deprotonation functions were calculated from stability constants 
obtained using the task s ZBAR and QBAR within EST A 1 module to find out if the 
model fitted the system. The models were approved to be correct when the observed and 
the calculated plots for the ZM and QM overlapped. 
Finally. the task SPEC within EST A 1 module was used to determine the species 
distribution as a functi,)n of pH for all species in the solution over the pH range of 2 to 
11. 
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3.3 RESULTS 
3.3.1 Glycine System 
The protonation and stabJlity constants for glycine equilibria were evaluated in the pH 
range 2-11. The overall protonation and stability constants were confirmed by the 
complete overlap of the calculated and the observed Z-bar and Q-bar plots. The 
logarithms of overall pro'onation and stability constants (log~pqr) of the glycine are given 
in Table 3.1 together with literature values. 
The protonation and stabllity constants were determined using ESTA library of computer 
speciation modeling programs. Initial guesses of the species and their constants were 
entered into input file. When the task BET A was used, with all guessed stability constants 
for a more general adjustment, the output gave modified values of the stability constants. 
The output values were hen replaced by modified guesses and were optimized together 
with the acid concentratit)n using the task OBJE to give the final values of the stability 
constants and the acid concentration describing the system. 
Table 3.1: log~pqr of glycire system are determined at 25°C and I 0.15 mol dm'3 (Cn Na+. 
s.dev denotes the standard deviation in log~pqr, R/I is the Hamiltonian R-factor and RlimH its 
limit, nTand np are the number oftitrations and points respectively. The general formula ofa 
complex is MpLqHr denoted by the stoichiometric coefficients pqr. 
p q r i log [3pqr i s.dev . log K i Rt I R Ii : lim I nT (np) Lit.Lj 
H-gly o 1 1 9.59 0.001 9.59 0.004 0.01 2 (202) 9.60 
012 11.96 0.003 2.37 2.37 
Cu-gly 1 1 0 8.11 0.007 0.002 0.01 2 (202) 8.20 
I 
I 120 14.91 0.009 l15.07 
L , i 
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3.3.1.1 H-glycine protonation 
The log~pqr obtained from EST A were entered into the input file of task Z-bar to give Zw 
bar plots in order to check if the model was correct The experimental and theoretical 
curves were obtained from flags 1 and 2 respectively in the task Z-bar of ESTA 1 module. 
1.60 
1.40 
1.20 
100 
"-(\I 
-9 
J: 
N 0.80 
0.60 
0.40 
0.20 
0.00 +----.----.---...----...---,----...----,----,------'; 
2.00 300 4.00 500 6.00 7.00 8.00 9.00 10.00 11.00 
pH 
Figure 3.3(a): Protonation formation curve, Zwbar against pH for glycine at 25°C in 
0.15 mol dm-3 (en Na-. The symbols represent titrations performed with different starting 
concentrations, [(+) 0.01 and (.) 0.008 mol dm-J ] and theoretical (solid line) curve. 
Figure 3.3(a) shows the proton formation function, Zwbar plotted against pH for glycine. 
The Zirbar function rises to slightly above 1.5 for this system indicating stepwise 
protonation of two sites of which only one is fully protonated in the pH range studied. 
The two expected protonated sites are from the amino and the carbonxl groups. The 
experimental and theoretical curves are well superimposabJe thus confirming the validity 
of the modeL The results in table 3.1 show low standard deviations and the Hamiltonian 
R-factor is less than its limit (RlimH) thus giving more confidence for this model. 
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In aqueous solutions, glycine exists as a zwitterion, the amino group being protonated 
(-NH/) while the carboxyl group is deprotonated (C02}23 The carbonxl group is 
protonated at pH 2-3 with pKa2 := 2.37 while the amino group with pKaJ 9.59 is 
protonated at pH 8-10 as shown in figure 3.3(a). The levelling offofthe curve at 1 shows 
the protonated amino group which begins to lose a proton in basic solution i.e. pH 8. The 
carbonxl deprotonation o.::curs at low pH where the accuracy of pH measurement is also 
low thus bringing about a slightly higher standard deviation than that of amino group. 
The pKa values obtained :ire in excellent agreement with those reported in the literature. 23 
100.00 
80.00 
III 60.00 
<Il 
'(3 
<Il 
a. 
III 
;,!1 
" 
40.00 
20.00 
0.00 +----,---;::=-..,----,---....,..-===:::;---.------,----, 
2.00 3.00 400 5.00 6.00 7.00 8.00 9.00 10.00 11.00 
pH 
Figure 3.3(b): Protonation species distribution curves for glycine (0.01 mol dm-3) as a function of 
pH. 
Figure 3.3(b) shows the distribution of the different protonated species of glycine as a 
function of pH. It shows that in the pH range 4 to 7.5, all of the ligand in solution is 
singly protonated and that deprotonated ligand predominates above pH 7.5. The plot also 
indicates that the double protonation has a very short pH span. This is because the 
carboxyl group deprotonates at a very low pH. 
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3.3.1.2 Cu(JI)-glycine complexation 
The 10gPpqr obtained from EST A were entered into the input files of the tasks Z-bar and 
Q-bar of EST Al module to give ZM-bar and Q-bar plots respectively. The experimental 
and the observed curves were obtained by flags 3 and 4 respectively for both plots. 
The stability constants (logPpqr) were evaluated and confirmed by the Z-bar and Q-bar 
functions from the experimental data. The complex formation function, ZM-bar, measures 
the average number of ligands bound per metal ion due to complexation. This function is 
plotted against negative logarithm of the ligand concentration (pL). 
The deprotonation functi·}n, Q-bar, which indicates the average number of protons 
released on complexation is plotted against pH of the solution. This function is compared 
with n-bar function whic1 measures the average number of protons that would be bound 
to the ligand in the absence of complexation. 
Figure 3 .3( c) shows the ZM-bar function for the Cu(II)-glycine system plotted against pL. 
The levelling off of the function at a value of 2 indicates the existence of the bis 
complexes of 1 :2 M:L ratio. The divalent copper coordinates with two molecules of 
glycine thus forming ML2 species. 
The Q-bar function given in figure 3.3(d) rises to two in the pH range - 6 indicating 
that two proton have bee 1 released into solution due to complexation. In this pH range 
the glycine has only one dissociable proton (n-bar 1) and no MLH.I or an MLH.2 
species is formed. ESTA analysis of the data gave the results in table 3.1. The divalent 
copper forms ML and M species with logppqo 's 8.11 and 14.91 respectively. The low 
standard deviations illustrate the reproducibility of experimental procedure. The rising of 
the Q-bar to two is a resdt of simultaneous coordination of two molecules of the ligand 
glycine per copperCJI) ion thus forming ML2 species. 
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There is no evidence ofhydroxo complex species from the above two functions curves. 
This is because eu(II) forms stable species with glycine. The results are in excellent 
agreement with those reported in the literature.23 
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Figure 3.3(c): Formation function curve, ZM-bar against pL for glycine at 25°C in 0.15 mol dm·3 
(Cn Na~. The symbols represent complexation curves for various metal to ligand ratios, 
[(+) 1 : 2 and (.) 1 : 3] and theoretical (solid line) curve. 
Figure 3.3(e) shows calculated species distribution curves for the Cu(II)-glycine system 
as a function of pH. Accl)rding to the species distribution plot, complexation starts 
around pH 2 forming ML species until about pH 4.5. The formation of predominant ML2 
species starts at pH 3. After pH 7 the solution contains mostly ML2 species and this 
concurs with the Q-bar curve levelling at 2. 
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Figure 3.3(d): Deprotonaton function curve, Q-bar against pH for glycine at 25°C in 0,15 mol 
dm'} (CI') Na+. The symbols represent complexation curves for various metal to ligand ratios, 
[(+) 1: 2 and (.) 1: 3] md theoretical (solid line) curve, 
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Figure 3.3(e): Species distribution curves of Cu(lI) and glycine (0.0067 mol dm,3, 1: 1, M : L 
ratio) as a function of pH. 
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The study of glycine system was performed in order to check the experimental procedure. 
The results obtained for the glycine system are very good and are in excellent agreement 
with the literature?3 Therefore, this gives us more confidence in studying a new system. 
3.3.2 peu A System 
The experimental proced ure perfomed for the determination of protonation and stability 
constants for PCUA sysh;~m is same as that of the glycine system. Potentiometric data 
was entered into ESTA Ibrary of computer speciation modeling programs for analysis. 
3.3.2.1 Protonation 
The protonation constants for lI-PCUA equilibria were evaluated in the pH range 2-1 L 
The overall protonation constants were confirmed by the complete overlap of the 
calculated and the obseryed Zwbar plots. The logarithms of overall protonation constants 
(log~olr) of the ligands are given in Table 3.2. 
Table 3.2: log~olr of PCU/\ determined at 25 and I 0.15 mol dm,3 (Cn Na+. s.dev denotes 
the standard deviation in lcg~olr , Rt is the Hamiltonian R-factor and Rlim H its limit, nI and np 
are the number oftitratiom and points respectively. The general formula of a complex is MpLqHr 
denoted by the stoichiometric coefficients pqr. 
Ligand p q r I lug r~pqr s.dev 10gK Rt RI II 1111 InT(np) 
PCUA o 1 1 9.52 0.01 9.52 0.03 0.01 i 2(168) • 
o I 2 17.81 0.02 
1
8
.
29 i i 
Figure 3.4(a) shows Zwbar function curve of PCUA. The function levels off at 2 
indicating that there are two dissociable protons from the primary amino groups in the 
PCUA ligand system. The overlapping of the experimental and the calculated Zwbar 
plots for different ligand concentrations and the low standard deviations of the 10g~Oqr 
confirm the validity of the proposed model. The titration curves show only one inflection 
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because the pKa values c f these amino groups are so close and that they are titrated 
virtually simultaneously. The two protonation constants correspond to proton additions to 
the primary amines with 10gKJ 9.52 ± 0.01 and logK2 = 8.29 ± 0.02. 
The difference between the first and the second protonation constants is 1.23 log units. 
The closeness of the comtants indicates proton additions to the two terminal primary 
amines. The difference in the constants is due to the addition of the proton to a molecule 
already containing a protonated site. 
2.00 ... --..--e-.... -.. ............. 
1.50 
... 
rG 
J:l x 1.00 
N 
0.50 
0.00 
2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11.00 
pH 
Figure 3.4(a): Protonation formation curve, Zwbar against pH for ligand PCUA at 25°C in 
0.15 mol dm-3 (Cn Na '. The symbols represent titrations performed with different starting 
concentrations, [(.) 0.0012 and (.) 0.0034 mol dm-3 ] and theoretical (solid line) curve. 
Figure 3.4(b) shows calculated species distribution for PCUA. The plots indicate that 
deprotonation of the doubly protonated PCUA ligand begins around pH 5.5 and neutral 
form of the ligand predominates in the basic pH region. It is also reflected in the 
protonation formation curve that the deprotonation of the ligand begins around pH 5.5. 
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Figure 3.4(b): Protonation species distribution curves for ligand PCUA (0.0034 mol dm") as a 
function of pH. 
3.3.2.2 Complex formation and deprotonation functions 
The stability constants (l,)g~pqr) were evaluated and confirmed by the Z-bar and Q-bar 
functions from the expermental data. 'T'he complex formation function, ZM-bar, measures 
the average number of ligands bound per metal ion due to complexation. This function is 
plotted against negative logarithm of the ligand concentration (pL). 
The deprotonation function, Q-bar, \vhich indicates the average number of protons 
released on complexation is plotted against pH of the solution. This function is compared 
with n-bar function whic:} measures the average number of protons that would be bound 
to the ligand in the absence of complexation. 
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3.3.2.3 Complexation with Copper(II) 
Table 3.3: log~pq, of PCUA with Cu(Il) determined at 25°C and 1= 0.15 mol dm-3 (Cn Na·. 
s.dev denotes the standard deviation in log~pqr , RrH is the Hamiltonian R-factor and Rhn/I its 
limit. nT and I1p are the number of titratlol1s and points respectively. The general formula of a 
complex is MpLqHr denoted by the stoichiometric coefficients pqr. 
Ligand p q r log Ppqr 
15.50 • PCUA 1 1 1 
1 1 0 9.96 
1 1 -1 2.71 
3.00 
2.50 
2.00 
... 
C'O 
.Q 1.50 I 
:i! 
N 
1.00 
0.50 
0.00 
2.00 4.00 6.00 8.00 
pL 
10.00 12.00 14.00 
Figure 3.4(c): Formation function curve, Zrvrbar against pL for ligand PCUA with Cu(II) at 
25°C in 0.15 mol dm-3 (CI') Na+. The symbols represent complexation curves for various metal to 
ligand ratios, ( ... 1: 2,.1 : 3 and +1: 4). 
Figure 3.4(c) shows the ZM-bar function for the Cu-PCUA system plotted against pL at 
various metal to ligand (oncentration ratios. The curves are non-superimposable 
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indicating the presence of species other than simple mononuclear species. The splitting is 
such that the bottom curve is for the ratio 1 : 2 and the top one for 1 : 4 metal to ligand 
ratio. The fanning back (If the curves at pL less than 4 is indicative of the formation of 
hydroxo and or mixed hydroxo complexes, Those possible hydroxo species are the 1 1 -1 
and 1 1 -2 as indicated in table 3.2. 
3.50 
3.00 
2.50 
2.00 
"-(II 
.0 
0 
1.50 
1.00 
0.50 
0.00 
3.00 400 5.00 6.00 7.00 8.00 9.00 10.00 
pH 
Figure 3.4(d); Deprotonation function curve, Q-bar against pH for ligand PCUA with Cu(lI) at 
°C in 0.15 mol dm·J (Cn Na', The symbols represent complexation curves for various metal to 
ligand ratios, (AI: 2,.1 : 3 and +1 : 4), 
Figure 3 A( d) shows deprotonation function curves as a function of pH. The Q-bar 
function curves indicat" that deprotonation begins above a pH value of 3.5 and these 
curves rise above a Q-bar value of2. The splitting pattern of the curves follows that of 
the formation curves. The n-bar shows that there are two possible dissociable protons on 
the ligand which are fwm the two amino groups. The rise of the deprotonation curves 
above Q-bar value of 2 is again an indication of hydroxo and or mixed hydroxo species. 
The falling of the curves at about pH 7.5 shows that complexation is complete. The rising 
of the curves at about pH 9 after levelling off at Q-bar = 2 is due the formation of 
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hydroxo species 1 1 -2. The presence of many different species was tested for using the 
BETA option in ESTA and using simulated data but the divergence of the curves at 
different M:L ratios could not be adequately expJained. 
The results given in table 3.3 shows log~ 's with low standard deviations and an 
acceptably low Hamiltonian R-factor. In addition, RH ~ Rlim so it is not satistically 
possible to improve the model. Therefore, based on these results and, Q-bar and Z-bar 
plots, the proposed modd is considered correct. 
100.00 ____ 
90.00 1 1 ·1 1 00 
80.00 1 1 0 
70.00 
60.00 
- 50.00 :J 
0 
~ 0 40.00 1 1 ·2 
30.00 
20.00 
1000 
0.00 
-
200 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00 
pH 
Figure 3.4(e): Species di5tribution curves of eu(II) and ligand PCUA (0.0013 and 0.0033 
mol dm·3 respectively) as a function of pH. 
From the species distribution curves above, different species predominate at different 
regions of the pH scale. A high % Cu(II) peak is observed for 1 1 -1 species at pH 8.5 and 
the lowest % Cu(ll) pelk is observed for 1 1 1 species at pH 5.2. The ZM-bar and Q-bar 
plots concur with the species distribution curves above. 
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3.3.2.4 Complexation with Zinc(II) 
Table 3.4: IogPpqr of PCU/\ with Zn(ll) determined at 25°C and 1= 0.15 mol dm-3 (Cn Na+. 
s.dev denotes the standard deviation in logPpqr , RtH is the Hamiltonian R-factor and RIIIl1H its 
limit, nTand np are the number oftitrations and points respectively. The general formula of a 
complex is MpLqHr denoted by the stoichiometric coefficients pqr. 
i log i3pqr s.dev IRT : R n I nT (np) I i 11m 
i -J 
PCUA I 1 1 1 13.~ 1 0.04 0.03 0.01 I 6~19 . () ) 
1 1 0 . 5.55 0.03 I / 
1 1 -1 1-2.93 0.04 
0.03 
Table 3.4 shows four species obtained in the complexation of Zn(Il) with PCUA ligand 
and their stability constants. The standard deviations are reasonably low and are not far 
from those obtained in the Cu(II)-PCUA complexation. The Hamiltonian R-factor is low 
thus giving confidence for the model chosen. The Z-bar function curves (figure3.5(a») 
does not level off at a Z!vl-bar of 1 thus indicating that the ML species are not the only 
species present. The curves resemble those of Cu(II)-PCUA in the splitting pattern when 
varying the metal to lig,md ratio. The fanning back of the complex formation function at 
a pL of 6.5 is indicative ofhydroxo and or mixed hydroxo species. 
The Q-bar function (figure 3.5(b») increases in the pH range of 4 to 7.8 followed by the 
steep or vertical increasr; from pH 7.8 indicating hydroxo species formation. This also 
indicates that complexation begins at about pH 4. At pH 9.5, the Q-bar and n-bar curves 
are parallel to each other indicating that no further complexation takes place. 
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Figure 3.5(a): Formation function curve, ZM-bar against pL for ligand PCUA with Zn(II) at 
25°C in 0.] 5 mol dm-3 (C n Na~. The symbols represent complexation curves for various metal to 
ligand ratios, (A,1 : L.l : 2 and +1: 3). 
From the species distribution curves (figure 3.5(c)), it is evident that the protonated 111 
species is present over ,} wide pH range. The hydroxo species formation begins at pH 7.5 
and this is in agreement with the Q-bar plot. The results show that PCUA ligand is a 
better complexer of copper(II) as compared to zinc(II). 
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Figure 3.S(b): Deprotonation function curve, Q-bar against pH for ligand PCUA with Zn(H) at 
°C in 0.15 mol dm ,3 (C n Na ~, The symbols represent complexation curves for various metal to 
ligand ratios, (,&1: 1,.1 : 2 and +1 : 3). 
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Figure 3.S(c): Species distribution curves of Zn(H) and ligand PCUA (0,00076 and 0.00 17 
11101 dm'} respectively) as a function of pH. 
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3.3.2.5 Complexation with Calcium(I1) 
Table 3.5: log~pqr ofPCUI\. with Ca(II) determined at 25°C and I 0.15 mol dm-3 (Cn Na+. 
s.dev denotes the standard deviation in logPpqr , R/' is the Hamiltonian R-factor and RlimH its 
limit nT and n1' are the number of titrations and points respectively. The general formula of a 
complex is MpLqHr denoted by the stoichiometric coefficients pqr. 
nT (np) [log Ppqr . s.dev 
f----+----,-- I ---+-----r-----r------i 13~:03 PCUA 1 1 1 
1 1 0 I 3.80 I 0.03 
-7.57 10.06 
0.01 6 (512) 
The results in table 3.5 ,how three species formed in the complexation of Ca(II) with 
PCUA. It is evident from the formation function curve (figure 3.6(a» that CaCH) forms 
only "veak complexes with PCUA under above conditions. The formation function curves 
do not increase to signiricant levels in the pH range investigated. The splitting pattern of 
the curves also resembl.= those ofCu(II)-PCUA and Zn(II)-PCUA systems. The 
deprotonation function curve (figure 3.6(b», Q-bar remains almost constant at a value 
close to zero indicating that there is very poor complexation or no complexation. 
However, ESTA gave stability constants reported in table 3.4. The 10gWs obtained have 
reasonably low standard deviations and are comparable to those of copper(II) 
complexation. The Hamiltonian R-factor is also low thus giving confidence for proposed 
model. 
Furthermore, the calculated species distribution curves (figure 3.6(c» show that the 
protonated species (111) is present in the whole pH range investigated. There are also 
free Ca2+ ions in the whole pH range investigated indicating uncomplexed Ca2+ ions in 
the solution. 
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Figure 3.6(a): Formation function curve, Z"1-bar against pL for ligand PCUA with Ca(H) at 
25°C in 0.15 mol dm'3 (C") Na +. The symbols represent complexation curves for various metal to 
ligand ratios, ( .. 1 : 1,.1 : 2 and +1: 3), 
"-
til 
.c 
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2.00 -------------_~ 
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0.50 . 
0.00 ._ ... a;~~~~==-::-.-..---.. 
3.00 4.00 5.00 6.00 700 
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Figure 3.6(b); Deprotonation function curve, Q-bar against pH for ligand PCUA with Ca(ll) at 
25°C in 0.15 mol dm"3 (CI") Na'. The symbols represent complexation curves for various metal to 
ligand ratios, ("1: 1,.1 : 2 and +1: 3). 
59 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
100.00 .-___ 
90.00 
80.00 
70.00 
:: 60.00 
'iii 
t> 50.00 
40.00 
30.00 
20.00 
10.00 
0.00 , =:::-;: 
5.00 6.0J 
100 
7.00 8.00 
pH 
1 1 1 
9.00 
1 1 0 
.~ 
10.00 11.00 
Figure 3.6(c): Species di~,tribution curves ofCa(Il) and ligand PCUA (0.00076 and 0.0017 
mol dm-3 respectively) as a function of pH. 
3.3.3 Discussion 
The protonation constants of PCUA and the stability constants obtained from 
complexation of PCUA with copper(II), zinc(II) and calcium(lI) are discussed in relation 
to diaminodiamide compounds (see abbreviations and structures in glossary). The 
proposed coordination ,tructures of PCUA with copper(II) are given in figure 3.7 and 
they will be discussed in detail in chapter 4. 
Table 3.6 shows protonation constants for the amino group of different diaminodiamide 
ligands. Protonation of the amide nitro gens was not observed. The first three ligands 
(5UH, 6UH and PCUA) from the table 3.6 have primary amines whereas the last two 
ligands(5UM and 6UM) have tertiary amines. The trend in the first protonation constant 
of these ligands shows an increase in the order 5UH<6UH<PCUA as the alkyl chain or 
group joining the two (mide groups is extended. A marked increase in the basicity is 
observed in the order 5UM<5UH or 6UM<6UH which indicate that primary amines are 
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more basic than tertiary amines. The trend in the second protonation decreases in the 
order 5UH>6UH>PCUA. 
Table 3.6: Comparison of the stepwise protonation constants of PCUA ligand with those of 
related diamino diamide ligands. 
! Ligand Species Log K I Medium / mol dm-J 
5UH o 1 1 9.31 0.1 KN03, 22 °CL4 . .i) 
012 8.43 
6UH • 0 1 1 9.40 " 
012 8.68 
PCUA o 1 1 9.52 0.15 NaCI, 25°C 
012 8.29 
SUM ° 1 1 8.72 0.15 NaCl, 25 °C
26 
012 7.91 
6UM o 1 1 8.83 ' ~ 
012 
1
8
.
07 
3.3.3.1 Complexation with copper(II) 
The complexation reaction ofPCUA with copper(II) was evidenced by a colour change 
from blue to blue green. The data analysis performed using EST A gave 1 1 1, 1 1 0, 1 1-1 
and 1 1 complex species with log Ws 15.50,9.96,2.71 and -7.05 respectively. 
Table 3.7: Stability constants of copper(II) with PCUA ligand and those of related 
diamino diamide and penLl-nitrogen donating ligands. 
~s_p_e_ci_e_s __ ~1_5_l_JH_2_6 ____ +i_6_U_II_26_· ____ ~P-C-I;-A----~-E-D-A------~B--ID-P-A-P--~ 
1 1 1 · 15.50 15.1 15.02 
1 1 0 9.41 7.93 9.96 10.5 8.91 
1 1 -1 6.37 2.71 2.07 • -0.896 
1 1 -2 ! 6.38 
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The proposed structures in figure 3.7 are used as a guideline for discussing the species 
formed. From these structures, 1 1 1 species seems to be formed by deprotonation and 
coordination of one of the terminal primary amines and one or both carbonyl oxygens to 
Cu2+. It has been observed from the speciation plots that 1 1 1 species is formed at 
relatively low pH. There is little stabilization of this species due to the binding of the 
neutral carbonyl oxygen(s) to Cu2+?8 
It is expected that as the pH increases, Cu(II) would induce ionization of the amide 
protons. There would also be a transition from Cu-O to Cu-N in coordination 
arrangement.27 The deplOtonation of one of the amide nitrogens with pKJiO = 5.54 
(lOg~lll - 10gllO) results in the 1 1 0 species. This low pK is due the deprotonation of an 
amide from already Cu( H) coordinated ligand. The 1 1 0 species is a subsequently 
converted to the 1 1 -1 complex by a coordination to the other amine group with 
pK ll . J = 7.25 (IOg~IIO - bgll·d. The 7.25 log units difference is comparable to the value of 
7,8 of the overall stabili ty constant of the second ammoniation of Cu(JI) ion.32 
The 1 1 -2 species formation is a result of loss of the second amide proton and the 
ditlerence in log units f'om 1 1 -1 to 1 1 -2 species is 9.76 (IOg~11.1-logll.2). The 9.76 
log units difference is a5sociated with loss of proton from amino origin on the complex. 
The formation of neutrd 1 1 -2 complex is observed at high pH. This species is formed 
when all the four nitrogens in the ligand are coordinated to the metal ion thus making 
5,105 membered ring. [t is reported that an increase in number of chelate rings around 
the metal ion results in large girdle strains thus influencing the stability of complexes 
formed,27 It was also found that sequence 5,5,5 was less favourable as compared to the 
5,6,5 or 6,5,6 membered rings. 31 
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Figure 3.7: Proposed coodination structures of copper(lI) with PCUA (coordinated water 
molecules have been omitted). 
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3.3.3.2 Complexation ·with zinc(II) 
The formation curves for Zn(II)-PCUA system indicate that very little complexation 
occurs before the formation of an hydroxo species at pL 5.6. This is evidenced by the 
fanning back of the Z-bar curves. However, the chemical model shows four complex 
species which are 1 1 1,1 1 0,1 1-1 and 1 1 -2 with log ~'s 13.81,5.55, -2.93 and -11.74 
respectively. The complexation ofzinc(Il) starts at a slightly high pH (above pH 4.6) as 
compared to copper(JI) which starts at pH 3. This is because zinc(II) is too weak an acid 
to promote amide deprolonation. However, the stability constants of ZnCH) complexes are 
also lower than those found for eueII). The species formation may be a result of 
coordination to the amine groups. Due to the electronic characteristics of the d'0 ZnCH) 
ion and its large size compared to Cu(II), Zn(II) ion does not favour deprotonation of the 
amide nitrogen.]] Therefore, the formation of 1 1 -1 and 1 1 -2 complexes may be due to 
ionization of the coordinated water molecule. Zn(H) easily form tetra-, penta- and hex a-
coordination geometries. However, zinc enzymes usually have coordination numbers 
fewer than six so that th,;y open reactive sites.34 
3.3.3.3 Complexation with calcium(II) 
There is very little or pc'or interaction between Ca(H) and peUA ligand in solution. This 
is also characterized by the formation ofhydroxo species and free ea(H) ions in the 
whole pH range investigated( figure 3.6(c)). However, three species formed are 1 1 1, 
11 o and 11-1 withlogWs 13.19,3.80and-7.57 respectively. Theformationofll ° 
species from 1 I 1 may be due to metal assisted deprotonation of the amine group with 
pK 110 = 9.39 (IOg~lll-logIIO). The observed species may also be a result of the 
coordination of the cart·onyl oxygen and water molecules.35 
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4. SPECTROSCOPY AND ANCILLARY STUDIES 
4.1 UV - VISIBLE SPECTROSCOPY 
4.1.1 Introduction 
Fascinating variety of colours among transition metal complexes arise from electronic 
transitions between energy levels whose spacings correspond to the wavelengths 
available in visible light. [n complexes, these transitions are frequently referred to as d-d 
transitions because they involve molecular orbitals that are mainly metal d in character. 
Since this spacing depends on factors such as geometry of the complex, the nature of the 
ligands present, and the oxidation state of the central metal atom, electronic spectra of 
complexes can provide valuable information related to bonding and structure. I As a 
result, CV -visible spectrophotometry is used as a supplementary technique to glass 
electrode potentiometry when ionic equilibria are investigated. 
The spectrophotometry provides an additional method for comparing possible chemical 
models not available with potcntiometry. However, because the UV/visible spectra of 
most complexes contain lxoad overlapping absorption bands, parameter correlation arises 
and therefore, it is not usually possible to evaluate stability constants as precisely from 
spectrophotometric data as compared to potentiometric data. The potentiometric data may 
lead to a more precise analysis of the wrong model, whereas spectrophotometric data will 
indicate the correct modc'l but give a less precise analysis of it Therefore, it is necessary 
to combine both spectrophotometric and potentiometric data for defining the chemical 
model and for evaluation of the stability constants respectively. 2 
4.1.2 Electronic Spectra of Metal Complexes 
Electronic spectra from transition metal ions and complexes are observed in the visible 
and ultraviolet regions. The spectra arise because electrons may be promoted from one 
energy level to another. The absorption spectra show the particular wavelengths oflight 
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absorbed, that is the particular amount of energy required to promote an electron from 
one energy level to a higher level, while emission spectra show energy emitted when the 
electron falls back from the excited level to a lower level.3 The absorption is observed in 
bands with the energy of each band corresponding to the difference in energy between the 
initial and final states. 
The relative intensities of absorption bands may be governed by a series of selection 
rules. According to Laporte rule the only allowed transitions are those with a change of 
parity, gerade to ungerade (g ~ u) and ungerade to gerade (u ~ g) but not g ~ g or 
u ~ u. This would mean that all d-d transitions in octahedral complexes are formally 
forbidden. Another rule states that transitions between states of different spin 
multiplicities are forbidden. For example, a cI configuration in an octahedral field would 
have three transitions that are spin allowed; 
However, there are mechanisms by which selection rules can be relaxed so that 
transitions can occur, eve n if only at low intensities. The bonds in transition metal 
complexes are not rigid but undergo vibrations that temporarily change the symmetry of 
the molecule. Therefore, d-d transitions of octahedral complexes result in low-intensity 
spectra. Tetrahedral com;)lexes often absorb more strongly than octahedral complexes of 
the same oxidation state. The spin selection rule breaks down somewhat in complexes 
that exhibit spin-orbit coupling. This results in bands associated with formally spin 
forbidden transitions gaining enough intensity to be observed. The spin-orbit coupling 
and Jahn-Teller distortions often lead to more complex spectra than predicted with spin 
selection rule. IJA.) 
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4.1.3 Electronic Spectra of Copper Complexes 
Many inorganic complexes including the copper complexes absorb in the visible region 
(400 - 700 nm). The chemistry of the copper(II) ion differs from that of the copper(J) ion 
in that while the latter ha5 a closed shell configuration (ArjdfO and forms diamagnetic and 
colourless complexes, the former has an incomplete d shell configuration (Al~d9 and its 
complexes are predominantly paramagnetic and highly coloured.6 The aqueous chemistry 
of copper is largely devoted to copper(II) compounds because copper(I) compounds are 
quite unstable in aqueous solution. Although Cu2+ can be dealt with as the equivalent of a 
one-electron case, the detailed interpretation of its spectra and magnetic properties can be 
somewhat complicated. However, copper(II) compounds show a single broad poorly 
resolved absorption band in the visible region. 
Copper(II) complexes arc generally blue due to absorption in the 540 - 800 nm region of 
the spectra. CuS045IhO and many copper(II) salts are blue. The addition ofNaOH to a 
solution containing Cu2+ gives a blue precipitate of the hydroxide. The hydrated ion 
[Cu(H20)6]2- is formed when hydroxide or carbonate are dissolved in acid or when 
CUS04 or Cu(N03)2 are dissolved in water. The ion has the characteristic blue colour 
associated with copper salts, and has a distorted octahedral shape. There are two long 
bonds trans to each other and four short bonds. This is called tetragonal distortion and is a 
consequence of the ~ configuration. I ,3.4,5. 
Most copper(lI) complexes and compounds have distorted octahedral structure. These 
compounds absorb in the region 11,000 16,000 cm-1 and show broad absorption band. 
However, octahedral complexes of copper(II) are appreciably distorted due to Jahn-Teller 
effect and so there is mOl e than one peak. These peaks overlap forming broad and 
unsymmetrical band. The octahedral arrangement causes crystal field splitting of the d 
orbitals on copper into lower energy 
are arranged (eg}6 and (12;/. Since 
and high energy 12g levels. The nine d electrons 
level is not symmetrically filled, Jahn-Teller 
distortion occurs. Thus the complex is distorted.3 
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Aqueous Cu2+ solution form many complexes with ammonia and ammines such as 
[Cu(H20)sNH3f+, [Cu(H~O)4CNH3)2]2+, CU(H20)3(NH3)3]2+ and Cu(H20h(NH3)4f+ It is 
difficult to add a fifth or ~,ixth NH3, though it is possible to make [Cu(NH3)6]2+ using 
liquid ammonia as a solvent. The value of L10 Cdifference in energy between orbitals) for 
the hexammine copper(II) ion is found in the range 10,200 - 10,700 cm"l. The ligand 
strengths of amines towards copper(II) are in the order NH3 > RNH2 > R2NH > R3N. In 
aqueous solution Cu2" iOIl has absorption and magnetic spectra which can be interpreted 
in terms oftetragonally distorted [Cu(H20)6f+ ion, the value of L10 being 12,500 cm"17 
The ligand field strength of water compared to other donors is shown by the order 
CI < H20 < pyridine < N H3 < 1,2-diaminoethane. 
Several complexes of copper(II) with polydentate ligands containing nitrogen have been 
studied and the type of complex formed by copper(II) with these ligands depends on both 
the number of the donor atoms and the steric requirements of the ligand molecule.7 
Copper(II) peptide complexes have been studied as models for copper(II) - protein 
interactions. It was observed that strong copper(II) - N(peptide) bonds are formed when 
protons are ionized from peptide nitrogen atoms. Other biological important donor atoms 
such as N(amino), N(imidazole), O(carboxylate), O(peptide), H20 and OR were 
studied.8 
Billo proposed a method for the calculation of total electronic transition energy 
contribution made by the donor atoms in the coordination sphere of the metal ion.s This is 
calculated by the formula; 
Veale LVi 
where Vi (xl03 cm"l) is the energy contribution by atom i. 
From the above equatior the contributions of each peptide and amino nitrogens to the 
Veale are (4.85 ± 0.04)xlC3 cm"l and (4.53 ± 0.07) xl03 cm-l respectively while that of 
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carbonyl oxygen, H20 anJ OH- is (3.01 ± 0.03) xl03 cm-Ieach and finally 
(3.42 ± 0.10) xl03 cm-I b:,r carboxylate oxygen.8 A value of3.38 X 103 cm-I was reported 
for oxime nitrogen [Cu(l-bdmg)CbJ (H2dmg = dimethyloxime, j"max 770nm). The 
effects of the rest of the atoms of the ligand molecule are assumed to be either negligible 
or additive onto the direcl effect of the coordinating atom via the molecular framework. 
The nature of electronic transitions that are brought about by chelating ligand can be 
inferred from the general observation of the effect of monodentate ligands on the ligand 
field parameter. Table 4.1 shows the guideline that is normally used for the estimation of 
the ligand field imposed by nitrogen-based chelating ligands. This is also relevant to the 
present study. 
Table 4.1: Absorption maxima of the copper(JI) ammine complexes of the general formula 
[Cu(NH3MH}Okn]2+ (Ref: 10) 
n I Absorption maximum (nm) 
.0 790 
1 745 
2 680 
3 645 
I 590 
4.1.4 Data Analysis 
A solution of metal ion and ligands will normally contain a number of different species at 
different concentrations. [hese species will contribute to the absorption spectrum and 
thus the final spectrum will be the sum of all the species present. It is therefore difficult to 
obtain the spectrum of a ;;ingle species. 
The Beer-Lambert-Bouger law, commonly called Beer's law, is the fundamental law 
governing the attenuatior ofradiation by a specific absorbing species in spectrometry. 
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According to this law, tht absorbance A of a solution is a linear function of the 
concentration of the absO"bing species as given by;2 
A log (loll) c:el . .4.2 
where 10 and I are the inknsities of the incident and emergent light beams respectively, 
c: is the molar absorption coefficient, c is the species concentration in mol/dm3 and I is 
the optical path length. 
For a given concentration and path length, the actual absorbance depends on the molar 
absorption coefficient of the absorbing species of interest. However, for the electronic 
absorption spectra of solutions containing more than one species the Beer-Lambert law 
can be expanded to give :inear combination of terms for each individual species. 
The absorbance Aobs, at wavelength·"A and when n species are present, is given by: 
.. 4.3 
where f} , E/ and c:n" are molar absorptivition coefficients of species 1,2 and n at the 
same wavelength "A, and c" C2 and Cn are their respective concentrations. If the path length 
is given in cm, 8/ is the molar absorption coefficient of the nth species in solution at 
wavelength Ie and has tht· units dm3 mol" cm· I.9 The linear dependence of Aob/ on the 
concentrations of various species present is an important feature in the equation. If a 
certain species has a value of EA equal to zero, then it does not absorb in the chosen 
spectral region and therefore does not influence Aob/ . 
Complexometric titration solutions may be made up of a number of solutions of different 
metal and ligand concen:rations, and pH. If the UV Ivisible spectra of these solutions are 
obtained at a number of wavelengths, then the spectra of the individual species can be 
calculated by solving a set oflinear equations (equation 4.3). It is recommended that 
adjustment of pH of the metal-ligand complex solution be made using strong acids and 
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alkalis such as Hel and l\aOH which do not absorb appreciably in the spectral region of 
interest. 
Calculation of the c; can be done using a specially designed computer program that 
requires an input file with all the information relevant to the chemical system being 
studied. The information includes amongst other parameters the concentration values of 
each chemical species present in the reaction. These concentration values are calculated 
on the basis of the stability constants obtained from glass electrode potentiometry. The 
values of c; are then plotted against wavelength to give a spectrum showing the absorption 
bands of each chemical species. Since the data is analyzed independently at each 
wavelength the existence of a smooth spectrum is not inherent in the data analysis and so 
if one is obtained it lends confidence to the experiment. If the stability constants and 
hence the concentrations ire not correct, the spectrum will be disjointed and this is 
indicative of a wrong chemical model. After having electronic absorption spectral 
information for each of tr·e complex species the nature of the ligand field environment of 
the central metal ion can be determined. 
A UV -spectra software program was developed in our laboratory in order to solve the 
expanded Beer-Lambert Law equation. The program deconvoluted the UV/visible 
titration data into the spectra of individual species.24 
4.1.5 Experimental 
Spectrophotometric titrations were performed for eu(JI) complexation with PCUA 
ligand. An aqueous solution containing 1 : 3 metal to ligand ratio was prepared and 
measured over the pH rarge 2-11. Small amounts of 0.1 mol/dm3 NaOH and 0.01 
mol/dm3 Hel were used to adjust the pH during the titration. The solutions were kept at 
temperature of 25°C. 
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Spectrophotometric measurements were taken automatically at 2 nm interval in the 
wavelength range of 340 820 nm using He\vlett Packard 8452A Diode Array 
Spectrophotometer. 
4.1.6 Results 
Colour changes were noticed during the titration process of Cu(II) with PCU A ligand 
indicating the formation of complex species in solution. It is worth noting that it was very 
difficult to obtain absoption sprectra at pH > 8. The spectra obtained were characterized 
by a lot noise or interferences and were therefore discarded. This may have resulted in 
missing the species forming at pH > 8. However, the absorption spectra were obtained in 
the pH range 3-8 as sho", n in figures 4.1 and 4.2. 
Table 4.2: Maximum wavelengths corresponding to their molar absorption coefficients for 
complexes of copper(II) with PCUA in solution. 
Species I g (dm3mor' cm- ) 
100 . 13.2 790 
1 I 1 27.4 720 
1 1 0 44.2 1660 
Figure 4.1 shows electro 1ic spectra of Cu2+ and PCUA in solution in the wavelength 
range 400-820 nm. It is observed that as the pH of the solution increases, the absorbance 
also increases. There is a shift in Amax from high to low as the pH of the solution is 
increased indicating the presence of different complex species. 
Figure 4.2 shows a plot of molar absorption coefficient, g, as a function of wavelength for 
Cu2-;- complex species with PCUA. The spectra show three complex species, 1 1 1, 1 1 0 
and 1 1 -1. The observed broad absorption bands for these species are due to the expected 
J 'B 'B 'B d ?E? . . 
. A 1 g ¢:::: - I g, - 2g ¢::::' / r an • g ¢:::: - B 1 g transItIOns. 
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Figure 4.1: Electronic specTa of solutions containing 0.0013 mol dm-3 Cu"' and 0.0036 mol dm-3 
PCUA as function ofwavel;;ngth. 
Table 4.2 shows molar extinction coefficients and their corresponding maximum 
wavelengths for the three species of Cu2+ and PCUA. The values of E increase in the 
order 1 1 1 < 1 1 0 < 1 1 1 while the corresponding Amax decrease in the order 
1 1 1 > 1 ] 0> 1 1 -1. 
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Figure 4.2: Calculated species absorption spectra of solution ofCu2+ and PCUA as a function of 
wavelength. 
4.1. 7 Discussion 
The UV/visible spectra of the complexes of the Cu2+ and PCUA gave three complex 
species as opposed to the four species obtained from glass electrode potentiometry. The 
1 1 -2 species is not observed from the UV /visible spectra because titrations were stopped 
at pH 8. The reason for this was that there were a lot of noise/interferences in the spectra 
at pH> 8. However, the ~,pectra of the three complex species were obtained in the pH 
range 3-8. 
The proposed structures nnd their details obtained using Billo's proposed method, are 
given in table 4.3 and figure 4.3. 
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Figure 4.3: Proposed structures for complexes species of Cu(II) with PCUA ligand and the 
corresponding calculated Billo's f"max. 
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Table 4.3: Details of the preJPosed structures for Cu2+ and PCUA. 
Species ) i ""max (nm) 
1 1 1 (a) U970 715 
(b) 1·+380 695 
1 1 0 (c) 15400 649 
(d) 15810 633 
1 1 -1 (e) 16920 591 
Cf) 1.5810 633 
(g) 15810 633 
(h) 17240 580 
i 13760 533 
The results given in table 4.2 for the complex species and their corresponding E 's and 
l"max'S, and those calculated using Billo's method in table 4.3 do concur with one another. 
The spectra of the complexes appear as broad spectral bands due to the nature of the 3 
possible transitions. I I The observable broad band of fvmax::: 790 nm with low molar 
extinction coefficient for the 1 0 0 species is due to the uncomplexed octahedral 
[Cu(OH2)6]2+ complex. 12 
For the MLH species in figure 4.3, structure (a) seems a more likely coordination 
geometry. The f'max calcdated from Billo's method and that obtained from the spectra are 
very close by 5 nm as compared to 25 nm for structure (b). The coordination geometry of 
the structure (b) may be destabilized by the rigidity of the cage moeity of the ligand in 
allowing both carbonyl oxygens coordination. 
Structure (c) seems to be the best representation of the ML species. It shows coordination 
of the amide nitrogen that was previously uncoordinated. The reason for structure (d) 
having relatively low ""mn: is due the transition of Cu-O to Cu-N when pH increases. 13 
The calculated ""max of 649 nm (Table 4.3) is more closer to the observed f'll1ax of 660 nm 
by 11 nm. Therefore, structure (c) is chosen as the best representation of 1 1 0 species. 
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For the MLH_I species, structures (e) and (h) have close calculated "-max values. The 
coordination geometry of structure (e) is the most likely to be formed as compared to 
structure (h) because the calculated "-max of (e) is the same as that obtained from the 
spectra. The "-max for (h) i) 11 nm less than the calculated value. The structures (f) and (g) 
have j,max's same as those of the ML species, therefore, may be overlapping with ML 
species. However, at high pH the carbonyl oxygens are less favoured over the amino 
groups. This results in the deprotonation of the amino groups. Although MLR2 species 
was not observed in the spectra, the structures (a), (c) and (e) lead to the proposed 
structure (i) with calculat(!d Icmax of 533 nm. 
The results obtained are comparable to those of [Cu(N1I3)n(H20)6-nf+ with Ivmax for the 
coordination of the first, second and third amino groups given as 745 nm, 680 nm and 
645 nm respectively. 10 The results are also comparable to those of diaminodiamide 
(SUM) (Table 4.1). The observed ;vmax for 5UM are 675 nm and 620 nm for 1 1 0 and 
11-1 respectively.1014 
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4.2 THE BLOOD PLASMA MODEL 
Metal ions play an imponant role in biological systems. Metal ions which are considered 
essential to human life indude those of calcium, magnesium, manganese, iron, cobalt, 
copper and zinc. 15 In biological fluids, the greater percentage of metal ions is bound to 
proteins. Actually, only a small fraction of these is bound to low-molar-mass (l.m.w.) 
compounds, mainly amino acids. Free (hydrated) metal ions exist in biological f1uids only 
at extremely low concentrations, and these concentrations cannot playa significant role 
. h . I . 1 16 In P ySlO oglca processes. 
The metal ions which are relatively loosely bound by other types of protein, and those 
which are complexed by the numerous l.m.w. ligands present and the free (aquated) metal 
ions, are competitive with the free metal ions. IS However, metals bound to l.m.w. 
compounds playa major role in many biological and physiological processes like 
intestinal absorption, cell absorption and renal excretion. 16 The Lm.w. complexes are 
believed to be involved () as intermediates when metal ions are inserted into or removed 
from certain metalloenzymes or carrier proteins, (ii) in the transfer of certain metal ions 
across membranes, (iii) in keeping essential metals in solution and (iv) in altering the 
potential of certain redox couples. Therefore, the knowledge of the equilibrium 
distribution of metal ions between Lm.m. ligands is highly desirable. IS'! 7,18 
Of interest in these l.m.In. complexes is copper. In blood plasma, 90% of the copper is 
irreversibly bound to ceruloplasmin, 10 % is reversibly bound to serum albumen and a 
small amount <1 % is distributed amongst Lm.m. complexes predominantly 
[Cu(histidate)( cystinate): .19 In patients with inflammatory disease, elevated levels of 
plasma copper are found and these levels return to normal upon remission. It is thought 
that the l.m.m. fraction of copper is responsible for anti-inflammatory activity, possibly 
by making the copper available to superoxide dismutase.2o 
The total concentrations of Mn(H), F e(III), Cu(II), Zn(II) and Pb(II) in normal blood 
plasma are between 1 x J 0.7 and 5 x 10.5 mol dm·3 .15,17 The corresponding minute 
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concentrations of the respective free ions are far below the limit of detection by any 
analytical technique. It is also very difficult to get information from large chemical 
systems because of their complexity. Because of these limitations computer models 
simulating the complex systems have been developed. 
Computer simulations of the metal-ligand equilibria in blood plasma have been 
performed using the general computer programs, COMICS and HALTAHALL.21 They 
were both limited in respect of the way they stored data and in respect of their equation 
solving algorithms. They could not, therefore, treat hundreds of components and tens of 
thousands of complexes which might reasonably be expected to form in a complicated 
mixture such as blood plasma.21 
For this reason, a specialized computer program was written in order to handle a large 
number of possible species. This was called ECCLES (for "Evaluation of Constituent 
Concentrations in Large Equilibrium Systems). 15 ECCLES solves the relevant mass 
balance equation and displays the resulting species distributions in ordered way to enable 
changes in concentrations of the major complexes to be readily monitored. One of the 
major features of ECCLES is its preprocessor MIX which generates estimates of the 
equilibrium constants for the many mixed (ternary) complexes that might be important in 
the blood plasma.21 Table 4.4 contains a list of the predicted most predominant l.m.w. 
complexes of copper present in the blood plasma. As can be seen, most of these 
complexes are mixed, ternary complexes of histidine and another amino acid. 
In order to understand the effect of the ligand (drug) on the equilibria present in this 
model, formation constants of the ligand and the species of interest determined in vitro, 
are incorporated into a database. This database, on inclusion of the drug concentration, is 
interrogated by the ECCLES computer program to yield results pertaining to the 
influence of this drug on these equilibria. 
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Table 4.4: Calculated % distribution of Cu(II) among its most predominant Lm. w. 
complexes in blood plasrna.22.23 
i Complex 
l.m.m. Cu(II) i 
Cu-Chis )(gln) 16.70 19.2 
Cu-(hish 17.50 15.5 
Cu-(his)(thr) 17.03 13.7 
Cu-(his)(ser) 16.97 7.5 
Cu-(his)(ala) 17.00 5.4 
Cu-Chis )(Lys )H+ 27.05 4.4 
Cu-(his )(gl y) 16.94 4.3 
Cu-(his)(asn) 16.81 4.2 
Cu-(his )(val) 16.93 3.9 
Cu-(his )(leu) 17.18 , 3.7 -~ ... ~ I 
Symbols: his histidinate, gIn = glutaminate, thr threoninate. ser = serinate, ala = alaninate, lys 
Iysinate, gly = glycinate, asn ~. asparaginate. val = valinate, leu = leucinate. 
One of the limitations of this program is that protein equilibria are not included and 
therefore the concept of plasma mobilizing index (pmi) is used. It is defined as the ratio 
of the total concentration ofl.m.w. metal complex species in the presence of the drug to 
that in normal blood plasma. In simple terms, pmi is a measure of the ability of the 
administered ligand to move the metal ion from the protein bound fraction to the l.m.w 
fraction. It is based on th~ premise that the free concentration of the metal ion is buffered 
and hence held constant during any reasonable perturbation. 
The l.m.w. fraction of copper(II) is postulated to be involved in the transport of the ion 
across the biomembranef, to anti-intlammatory processes. Therefore, the study of this 
blood plasma model is done to measure the availability of the metal ion to the anti-
inflammatory processes by l.m.w. ligand pellA. 
82 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
4.2.1 Simulation Studies 
In investigating the copper specificity of the ligand of present study, the 
potentiometrically determined stability constants for copper(II), zinc(II) and calcium(II) 
complexes were put into the ECCLES model of blood plasma so as to calculate the 
plasma mobilizing indices. The inclusion of ZnCH) and CaCH) is due to their high 
concentrations in blood plasma relative to CueII).l5 In the calculation, the total ligand 
concentration was raised over the range 10-2-10° mol dm -3. The results are given in 
figures 4.5 and 4.6. 
5UM 
PCCA 
Figure 4.4: Structures ofPCUA and SUM 
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Figure 4.5: Logarithms ofCu(II) plasma mobilizing index as a function of logarithms of the 
ligand concentration for PCLJA and SUM ligands. 
o 
Figure 4.5 shows the pmi curves as a function of log[ligand] for the ligands PCU A and 
SUM. These pmi curves il1dicate that the ligand PCllA is better able to mobilize copper 
than SUM. However, the log pmi value of 0.22 at 1 M concentration is still unreasonable 
t(X biological systems. Therefore, it cannot effectively increase the I.m.w. copper(II) 
fraction. One of the reasons for this low mobilizing ability is the stability of the PCUA, 
Zn(II) and Ca(lI) complexes. This is shown in figure 4.6. A 10.1 concentration of 
PCUA causes a 30 fold ircrease in the l.m.w. Ca(Il), a 2 fold increase in I.m.w. Zn(II) 
and no change in the l.m. w. concentration of Cu(II). 
Figure 4.6 shows the the pmi curves for Cu(II), Zn(II) and Ca(H) with PCUA as a 
function oflog[PCUA]. The curves indicate that the mobilizing ability ofPCUA is in the 
order Ca(H) > Zn(II) > Cu(Il). This shows that zinc(II) and calcium(ll) are competitors of 
copper(lI) in blood plasma. This illustrates the need for simulation models and inclusion 
of other competing metal ions in the study. Looking at the stability of the Cu(II) complex 
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alone is not sufficient because as in this case the Ca(II) and Zn(II) being present in much 
higher concentrations are able to compete for PCUA. 
2.5 
2 
1.5 
'§ 
c. 
Cl 
.2 
0.5 
o~--==~==~----~----~====~----~---c~== __ 
-3.5 -3 -2.5 -2 
log[PCUA] 
-1.5 -1 -0.5 o 
Figure 4.6: Logarithms of Cu(II), Zn(II) and Ca(II) plasma mobilizing indices as a function of 
log[PCUA]. 
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4.3 NUCLEAR MAGNETIC RESONANCE 
4.3.1 Introduction 
Nuclear magnetic resonance (NMR) is an important tool in the investigation of 
chemical structures and reaction mechanisms. It has been extended to whole body 
imaging in medical diagnosis. In this study NMR is used to determine the sequence of 
protonation of the two am ine groups of PCU A. The presence of the proton is expected 
to shift the NMR signal arising from protons attached to the neighbouring carbons. 
Upon complexation with copper(Il), the presence of the metal is expected to broaden 
and shift the signal arising from protons attached to the neighbouring carbons. 
3.2.2 Experimental 
In 5ml glass vials. one millimetre portions of 0.0 15 M stock 0 20 solution of PCUA 
ligand were prepared and the I H NMR spectra were recorded at 300 MHz. The pH of 
the solutions was adjusted using concentrated NaOH and HCI. Tertiary butyl alcohol 
was used as a reference. A micro-pH 2000 meter was used to measure the pH of the 
solutions. The pH of the solution may be calculated using the relationship; 
pO = pH + 0.4 
For copper(Il)-PCUA complexation, solutions of 1:2 molar ratio of metal to ligand 
were prepared in D20 and scanned in the pH range 4-11. The magnetic resonance 
spectra of both protonation and complexation were plotted as function of pH. 
PCUA 
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4.3.3 Results and Discussion 
Figure 4.7 shows proton NMR spectra for protonation ofPCUA in D20. As the pH of 
the solution increases, some of the NMR signals shift to low ppm values. The shift is 
a result of proton at ion to the amine groups. A significant chemical shift is observed 
10.0 __ ~~...N--~--'"' 
9.1~, 
a 
c 
b 
I I I I I I iii i I I I I I I I I I I 
2.5 2.0 1.5 1.0 0.5 -0.0 
Figure 4.7: Proton NMR spectra ofPCUA as a function of pH. 
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for protons attached to carbons next to the amine groups followed by those next to the 
amide groups. 
Figure 4.8 shows plots of proton chemical shifts as a function of pH, where (a), (b) 
and (c) refer to the chemical shifts of the protons attached to carbons next to the 
carbonyl groups, amine groups and amide groups respectively (ligand structure given 
in figure 4.7). There is no significant change in the chemical shift of the (a) protons as 
compared to (b) and (c) protons. This is because protons at this position are far from 
the amine groups where protonation takes place. However, a more significant change 
is observed for protons (b). Other protons on the cage moiety show very slight shift 
or no shift becaus~ they are further away from the site of protonation. 
2.4 
(c) • 
2.2 ~ 2 E 
-0-
0-
.!: (b) 
~ 
~ 1.8 
c;; 
0 
'E 
'" J: 
t) 1.6 
(a) 
1.4 
1.2 +----'T""'"---....... ---....... ---r----__ ~--__ ~--......, 
5 6 7 8 9 10 11 12 
pH 
Figure 4.8: Change in proton chemical shift (ppm) as a function of pH. 
The plots of change in proton chemical shift show average pKa value of 9.5 which is 
in good agreeme'1t with the value of 9.52 obtained from our potentiometric studies. 
Figure 4.9 show~. the spectra for complexation of copper(IJ) and PCUA as function of 
pH. Since copper(II) is paramagnetic, it tends to broaden and shift signals arising 
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from protons attacned to neighbouring carbons. From the species distribution curves 
in figure 3.4(e), complexation offree ligand starts at pH 4 and, therefore we expect a 
change in the NMR spectra at pH > 4. From figure 4.9, signals (a), (b) and (c) broaden 
and shift as pH increases. The signal arising from protons attached to carbons next to 
the amine groups virtually disappear at pH 7.S due the closeness of the eu(II) ion. 
This indicates that either one or both amine groups are coordinated to the metal ion. 
However, the signals arising from protons attached to carbons next to the amide 
groups also broaden and shift to low ppm values. This is indicative of coordination of 
the metal ion to at least one amide group as pH increases from 4-11. The signals 
arising from protons which are further away from the site of coordination slightly 
broaden and shift to low ppm values. 
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Figure 4.9: Proton NMR spectra for complexation of copper(II) with PCUA as a function of 
pH. 
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5. GENERAL DISCUSSION AND CONCLUSION 
The role of copper(II) in biological systems and processes is well known. L2 The 
elevation of COPPfr(IJ) complex species in the plasma and synovial fluids of 
rheumatoid arthritic (RA) patients is known? It was also found that a number of 
Cu(II) chelates exhibit anti-inflammatory activity. Therefore. several studies have 
been carried out in designing chemically stable copper complexes for use in anti-
arthritic agents. 
The present study has been designed to contribute to the development of the anti-
arthritic agents. However, the suitable ligand must be able to complex copper and 
enhance the transportation across a biomembrane. It is also required that the ligand 
must be able to c(lmpete with histidine for copper in plasma or form ternary 
complexes ofhistidine.2 
This study investigated the solution equilibria ofH4 , Cu2+, Zn2+ and Ca2+ at 25°C and 
in 0.15 mol dm-3 cr(Na +) using glass electrode potentiometry. These metals were 
studied with the ligand PCUA. 
PCUA has been found to take up two protons in the pH range 2-11. The observed 
protonation constants agree with those of related diamino diamide ligands and their 
analoques. From the complex formation and deprotonation functions, the stability 
constants reported were chosen as the best possible to describe the solution 
thermodynamics of this system. Moreover, the reasonably low standard deviations in 
log~pqr's and the low Hamilton R-factor give confidence to the proposed model used 
in the data analysis. 
Potentiometric data analysis by EST A gave four possible species MLH, ML, MLRI 
and MLR2. Bec3use copper(II) forms coloured complexes with the ligand, the 
coordination geonetries of the complex species present in solution have been 
confirmed by U\,Nis spectrophotometry. The spectra for MLR2 is not observed 
because it was di fficult to obtain spectra at pH>8. However, spectra were obtained for 
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three complex species and spectroscopic measurements indicate that Cu2+ sits in a 
square planar environment of nitrogen donor atoms in the MLH_I species. 
Zinc(II) and calcium(II) ions being present in blood plasma in large concentrations are 
regarded as potemial competitors of copper(JI) in vivo.34 However, zinc(II) 
complexes are likl~ly to predominate at physiological pH because of its high 
concentration and the ability to form complex species at this pH. From the pmi 
results, PCUA ha~; been found to be a better copper mobilizing ligand as compared to 
SUM which is alsJ a diamino diamide ligand. However, the pmi of PCUA is still very 
low it to compete with other I.m.w. species in blood plasma. Moreover, Zn(II) and 
Ca(H) have been ;Qund to be competitors of copper(II) for PCUA in blood plasma. 
NMR studies carried out supported protonation ofPCUA and complexation with 
copper(II). The protonation ofthe amine nitrogens was observed as pH increased 
from 2-11. Therelore, influencing the chemical environment of the protons attached to 
carbons next to the amine groups. Upon complexation with copper(II), the observed 
peaks broadened 3.nd shifted, thus confirming complexation of PCUA with copper(II). 
Although complex species of PCUA with copper(lI) were found to have little plasma 
copper mobilizing ability, the results in a way contribute to further investigations of 
anti-arthritic agents. In order to increase stability of complex species, Sand 6 
membered rings should be maintained in chelate rings. Finally, the search for new 
ligands must conI inue. 
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